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Interfacial behaviour of -sheet forming antimicrobial peptide GL13K  
Hala Youssef, Ph. D. 
Concordia University, 2019 
Antimicrobial peptides (AMPs) have been proposed as promising alternatives to conventional 
antibiotics. They are highly selective and efficient bactericidal agents that are already present as 
elements of innate immunity. GL13K is a synthetic peptide, derived from residues 141-153 of 
the human parotid secretory protein, and it is an AMP that is bactericidal against Gram-positive 
and Gram-negative bacteria. Previous biophysical studies with this peptide showed that it 
selectively forms -sheets in the presence of anionic membranes and targets membranes via the 
carpet method.  
In this thesis, initial studies focused on the surface behaviour of GL13K to determine whether it 
has the propensity to form amyloidic structures. Once it was established that GL13K does not 
aggregate into amyloidic fibrils at the air/water interface or when transferred to solid support, 
studies with anionic monolayers of varied membrane fluidity were conducted using 
dioleoylphosphatidylglycerol (DOPG) and mixed DOPG:cholesterol and 
DOPG:diphytanoylphosphatidylglycerol (DPhPG) films. Both cholesterol and DPhPG, a  
branched, anionic lipid, lower the permeability of membranes, but only cholesterol increases 
membrane viscosity. These studies showed that membrane viscosity plays a greater role in the 
prevention of peptide insertion into membranes. This suggests that cholesterol may contribute to 
the protection of eukayotic cells from AMPs by attenuating peptide insertion. 
Some bacteria have developed resistance to AMPs by upregulating the production of lysyl-
phosphatidylglycerol (LPG) to mask the negative charge on their membranes. Model membranes 
consisting of dipalmitoylphosphatidylglycerol (DPPG) and mixtures of DPPG and DP3AdLPG, 
a stable analogue of LPG, were used to determine how this lysylation alters GL13K behaviour at 
the air/water interface. The functionalization of the headgroup attenuates the formation of 
crystalline -sheets by disrupting the hydrogen bonding network. Peptide crystallinity appears to 
 
 iv 
increase when the peptide is bound to the headgroup region which could either attenuate activity 
or alter the mechanism of activity. This highlights the need for further research in this area to 
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Chapter 1. Introduction 
1.1. Motivation 
The abuse of antibiotic prescription and administration in humans as well as in livestock and 
agriculture has resulted in pathogens that have developed multiple mutations rendering them 
resistant against various antibiotics.
1
 In the race to treat infections by these pathogens, higher 
dosages of these antibiotics are being administered and the escalation is increasing the cost of 
available treatments while reducing their efficacy.
2,3
 The international post-antibiotic era is 
imminent and has already begun in many developing countries, with the example of India where 
the majority of adults are carriers of -lactam-resistant bacteria.
4
 The World Health Organization 
(WHO)’s most recent global report shows highly resistant bacteria in most WHO regions, and 
the list of antibiotic-resistant pathogens is long and continuing to grow as these pathogens are 
becoming multidrug-resistant (MDR) and spreading quickly.
5
 It was projected that within the 
next thirty years, antimicrobial resistance (AMR) will cause more deaths than cancer (Figure 
1.1).
6
 One of the promising fields of study to find alternative treatments is antimicrobial peptide 
research. 
 





1.2. Antimicrobial peptides 
Natural antimicrobial peptides are an integral part of innate immunity in both the plant and 
animal kingdoms as they are effective against a large range of pathogens, including bacteria, 
fungi, viruses and protozoa.
7
 They are typically cationic, ranging between 10 and 100 amino 
acids, and they can fold into amphipathic structures in the presence of bacterial membranes. 





Figure 1.2 Examples of AMPs from each family, where their classification is indicated on 
the bottom left of each panel
8
 
There are various databases in which AMPs have been compiled including the Antimicrobial 
Peptide Database (APD). The APD is a database that has been manually curated and includes 
peptides of known, or partially known, sequences that have been demonstrated to be 
antimicrobial. To date, 3117 antimicrobial peptides have been registered with the University of 
Nebraska Medical Center (UNMC)’s Antimicrobial Peptide Database (APD). The vast majority 
of these peptides contain fewer than 100 amino acids and are from natural sources, though they 






1.2.1. Activity-helical vs. -sheet forming AMPs 
Membrane disrupting AMPs tend to adopt amphipathic secondary structures and the most 
common AMP secondary structure is -helical. Many of the well-known AMPs fall into this 








 There are far fewer 
AMPs that fold into -sheets, and most of those require disulfide bridges to maintain their 
secondary structure. Arenicin-1, protegrin-1, and tachyplesin are AMPs that form -hairpins 
which are stabilized by disulfide bridges.
14–16
 Capistruin and the lariatin peptides have disulfide 
bridges that stabilize the formation of a lasso-like structure, where the -sheet holds the lasso 
together and greatly contributes to the stabilization of the overall structure.
17,18
 Other -sheet-
forming peptides are cyclic e.g. gramicidin S, defensin, and labaditin.
19–21
 While most AMPs are 
unstructured in solution and undergo a conformational change upon interaction with a 
membrane, cyclic peptides are structured in solution which may contribute to their higher 
bactericidal efficiency.
22
 The forced conformation induced by disulfide bridges has also been 
shown to be important for bactericidal activity.
22–24
 
1.2.2. Functional relationship between AMPs and amyloids 
-sheet-forming amyloids have been linked to numerous neurodegenerative diseases including 
Parkinson’s disease, Alzheimer’s disease, spongiform encephalopathies (mad cow disease), and 
type II diabetes.
25
 Amyloids have antimicrobial properties, where the intermediate amyloid 
oligomers were more effective than the monomers or the fibrils.
26–28
 While there is no distinct 
sequence conservation among amyloid  (A) peptides, prion proteins (PrP), and islet amyloid 
polypeptide (IAPP), all three form the characteristic cross- structure.
29
 It has been proposed that 
there is a functional link between antimicrobial peptides and amyloids. Amyloid fibril formation 
appears to be dependent on a nucleation seed
30–32
 and self-complementing -sheets that form 
interdigitated hydrophobic zippers.
26,29
 However, experimental and computational findings 
suggest that a propensity to form -sheets does not necessarily imply fibril formation.
33,34
 While 
both AMPs and amyloids contain a larger proportion of hydrophobic residues, amyloids are not 
usually charged. While de la Paz et al. even suggested that high charge prevents fibril 
formation,
33
 protegrin-1 was found to undergo amyloidosis and form fibrils at a much faster 
kinetics than A 1-42
35
 despite its +7 net charge.  
 
 4 
1.3. AMP mechanisms of attack 
Initially, three AMP mechanisms of attack were proposed: the barrel-stave, toroidal pore, and 
carpet mechanisms (Figure 1.3).
36
 They all begin with the accumulation of the peptide in the 
outer leaflet, parallel to the membrane. The barrel-stave and toroidal pore mechanisms are 
similar: after accumulation in the membrane to a threshold concentration, the peptides reorient to 
form transmembrane pores that cause bacterial death. The main difference between the two 
mechanisms is that the pores formed by the toroidal pore mechanism are composed of both 
peptides and lipids.  
 
Figure 1.3 Traditional AMP mechanisms of attack, showing accumulation of peptide in the 




The third mechanism of attack is the carpet mechanism where the AMPs remain parallel to the 
membrane until the saturation limit at which point they cause fragmentation of the outer leaflet 
and, subsequently, membrane disruption. It is referred to as the detergent mechanism as there is 
no pore formation only local ‘transient’ pores. As the library of known antimicrobial peptides 
has grown, additional mechanisms of attack have been proposed (Figure 1.4). Though these 
mechanisms appear to be variations of the three main mechanisms, they vary significantly from 
each other. These ‘new’ mechanisms include the disordered toroidal pore,
38
 the membrane 
thickening,
39




 and the non-lytic membrane 
depolarization
42
 mechanisms. No direct correlation has been established between peptide 









1.4. Human parotid secretory and the GL13 peptides 
The human parotid secretory protein (hPSP), otherwise known as short palate, lung and nasal 
epithelium clone 2 (sPLUNC 2) or human salivary protein BPIFA2,
44
 is a human salivary protein 
that is structurally related to the bactericidal/permeability increasing protein (BPI), the 
cholesteryl ester transport protein, and the lipopolysaccharide-binding protein (LBP), with a 
sequence similarity of 22%.
45
 Bactericidal activity assays showed that it binds 
lipopolysaccharide (LPS) and is bacteria-agglutinating.
45,46
 By using the sequence of hPSP and 
the known structure of BPI, various peptides were made with the goal of designing a new 




Figure 1.5 Structure and sequence of hPSP, where the sequence used in the design of the 




Various peptides were designed based on the known behavior of BPI and BPI peptides, and the 
C-terminus of the GL13 peptides was amidated to increase their positive charge. The peptide 
GL13K was designed based on the hemolytic, hemoagglutinating, and bacteria-agglutinating 
characterization of the wild-type sequence peptide GL13NH2.
47
  
Table 1.1 shows the sequences and some properties of the three GL13 peptides of interest. 
GL13NH2 is positions 141-153 of PSP’s sequence with an amide-functionalized carboxy-
terminus. The modification of GL13NH2’s aspartate at position eleven to an asparagine 
increased the net positive charge of the peptide from +1 to +2 (Table 1.1) and weakened its 
selectivity (Table 1.2). The residues in GL13NH2 at positions two, five, and eleven were 
changed to lysine to increase the net positive charge of GL13K. These modifications induced 
bactericidal activity in GL13K. GL13K is effective against bacteria of very different membrane 







Peptide Sequence Charge at physiological pH pI 
GL13NH2 GQIINLKASLDLL-NH2 +1 10.1 
GL13D/N GQIINLKASLNLL-NH2 +2 14 
GL13K GKIIKLKASLKLL-NH2 +5 14 
Table 1.1: Properties of the GL13 peptides 
 





Biological activity GL13NH2 GL13D/N GL13K 
Bactericidal Yes Unknown Yes 
Effective against 
biofilms 
No Unknown Yes 
Inhibits TNF-α secretion Yes Unknown Yes 
Hemolytic No 
Yes 
(Not in the presence 




(Not in the presence 
of 5% serum) 
Yes No 
Bacterial agglutinating Yes Yes No 
 
 8 
1.4.1. Biophysical characterization of GL13 peptides 
The structural behaviour of GL13NH2, GL13D/N, and GL13K has been studied by various 
biophysical techniques, with GL13K being the most studied due to its potential as an 
antibacterial therapy. While GL13K is highly soluble and remains unstructured in solution, 
GL13D/N and GL13NH2 are much more hydrophobic and, subsequently, fold into both -
helices and -sheets in solution.
49
 This pre-folding appears to drive membrane insertion and 
lower the peptide’s specificity. GL13K, on the other hand, is highly specific for anionic 




1.5. Compositional differences between bacterial and eukaryotic 
membranes 
1.5.1. Phospholipid composition and membrane charge 
One of the most significant differences between bacterial and eukaryotic membranes is the 
charge of the outer membrane. While the proportions of negatively-charged phosphatidylglycerol 
(PG) headgroups and phosphatidylethanolamine (PE) vary between Gram-positive and Gram-
negative bacteria, bacterial plasma membranes consist predominately of anionic lipids.
7,51,52
 The 
cell wall of Gram-positive and the outer membrane of Gram-negative bacteria are also both 
anionic due to the presence of lipoteichoic acid (LTA) and lipopolysaccharide (LPS), 
respectively (Figure 1.6).
51
 Eukaryotic membranes, on the other hand, are predominately 
zwitterionic. The main components are phosphatidylcholine (PC), phosphatidylethanolamine 






Figure 1.6  Structural differences between the membranes and bacterial envelopes of 
Gram-positive and Gram-negative bacteria
51
 
Another significant difference between bacterial and eukaryotic membranes is that eukaryotic 
membranes are significantly more rigid due to the presence of cholesterol and sphingomyelin 
which increases the ordering and packing density of the bilayers.
54
 
1.5.2. Cholesterol in model membranes 
Cholesterol (Ch) is a known membrane rigidifier. Cholesterol concentration in eukaryotic 
membranes varies in the 20-40 mol% range.
55,56
 The incorporation of cholesterol into 
membranes has been shown to decrease membrane permeability and hinder the incorporation of 
peptides into the lipid bilayer.
57–59
 
Due to its structure (Figure 1.7), cholesterol intercalates within the hydrophobic tails of the lipid 
bilayer with its single hydroxyl functional group oriented into the headgroup region.
60
 The 
interaction of the rigid sterol ring with the acyl chains reduces the mobility of neighboring lipids 
and increases the spacing between the lipid headgroups.
61
 Additionally, cholesterol causes de-
wetting of lipid head groups, altering the dipole of the membrane.
62
 While there is experimental 





 other studies have shown the formation of specific, ordered 
cholesterol/phospholipid superlattices.
56,65–67
 The miscibility of cholesterol in membranes varies 
depending on the lipid acyl chain length and level of saturation as they both contribute to 
transition temperature.
60
 The miscibility of cholesterol is also influenced by headgroup 
structure.
68
 In fluid membranes, cholesterol condenses the acyl chains via short-range (local) 
ordering, while it fluidizes liquid-ordered membranes by disrupting long-range (global) 
order.
56,60,67,69,70
 Cholesterol can increase the viscosity of DOPC membranes by ~16% when the 
mole fraction of cholesterol (cholesterol) is 0.4.
71
 
1.5.3. Studies with branched phospholipids 
While cholesterol may not be present in bacterial membranes, branched lipids, particularly iso- 
and anteiso-branched lipids, are found in abundance.
72
 The branched lipid that will be used in 
this study is diphytanoylphosphatidylglycerol (DPhPG), as the methyl-branched chains are found 
in archaebacterial membranes and not mammalian membranes (Figure 1.7).
73
 
These lipids are chemically stable synthetic archael lipids that can form stable bilayers.
74
 A 
molecular dynamics study comparing diphytanoylphosphatidylcholine (DPhPC) with 
dipalmitoylphosphatidylcholine (DPPC) concluded that DPhPC bilayers have slower rotational, 
translational, and chain-wobbling motions but faster headgroup wobbling and rotation.
61
 X-ray 
and neutron scattering and permeability studies on DPhPC bilayers, and they concluded that 
DPhPC’s bilayer thickness was similar to that of DOPC and that the branching in DPhPC lowers 
water permeation through the hydrocarbon region of the bilayer.
73–75
 While Hung et al. proposed 
that these methylene groups on the lipid chains interdigitate,
76
 studies with giant unilamellar 
vesicles (GUVs) and supported bilayers concluded that phytanoyl membranes are highly fluid 
and have very disordered acyl chains.
77
 Differential thermal analyses confirmed that DPhPC 
bilayers do not form gel phases over the range from -120 to 120 °C,
78
 and neutron reflectivity 
showed that the phytanoyl lipids occupy a larger volume per lipid molecule than 
paltimoyloleoylphosphatidylcholine (POPC) due the methyl branching on the acyl chains.
79
 
Diphytanoylphospholipids have been used to study AMP insertion mechanisms
80–83
 despite the 
effect of branching on peptide insertion not being well defined.   
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Figure 1.7 Lipid structures of 1,2-diphytanoyl-sn-phosphatidylglycerol (DPhPG) and 
cholesterol (Ch) 
1.6. Bacterial resistance to AMPs 
In the early years of antimicrobial peptide research, it was speculated that bacteria would not 
develop resistance to AMPs as this would require that bacteria develop mechanisms by which to 
modify their membranes.
84
 It was later discovered that bacteria could develop resistance to 
AMPs, and the mechanisms by which they have become resistant are diverse and vary from 
species to species. Some examples include upregulation of protease production or modulation 
and subsequent masking of the negative charge of their membranes via D-alanylation of teichoic 
acids, acylation of the glycerol of PG headgroups, or amino-functionalization of 
phospholipids.
52,85–87
 Of these, the most commonly studied amino-functionalization is the 
lysylation of phosphatidylglycerol headgroups. 
1.6.1. The role of lysyl-phosphatidylglycerol 
When resistant strains of S. aureus undergo stress e.g. growth at lower pH or in the presence of 
AMPs, they upregulate the multiple peptide resistance factor gene (MprF) which encodes the 
enzyme aminoacyl-PG synthase which is responsible for the lysyl-modification of the 
negatively-charged phosphatidylglycerol headgroups and translocation of the lysyl-
phosphatidylglycerol (LPG) to the outer leaflet of the plasma membrane.
88,89
 Rehal et al. found 
that the proportion of lysyl-phosphatidylglycerol in the membranes of methicillin-resistant 
strains of S. aureus (MRSA) was greater in cultures grown at pH 5.5 as compared to those grown 
at pH 7.4.
90
 The cultures grown at pH 5.5 contained ~55% LPG, while those grown at pH 7.4 
contained ~30%. 
This modification shifts the net charge of LPG to either +1 or to net neutral, depending on the 
protonation state of the phosphate (pKa ~3),  the alpha amine (pKa ~6.5), and the epsilon 
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(terminal) amine (pKa ~10).
91–93
 Rehal et al. proposed that the epsilon amine loops up to interact 
with the phosphate of the LPG, a neighboring cardiolipin or DPPG in the membrane.
93
 Due the 
labile nature of the ester linkage in the lysyl-phosphatidyl headgroup,
93,94
 a stable synthetic 
analogue, 1,2-dipalmitoyl-3-azo-dehydroxy lysyl-phosphatidylglycerol (DP3adLPG), was 
synthesized (Figure 1.8). Previous studies used model membranes comprising  





Figure 1.8 Chemical structures lysyl-phosphatidylglycerol (LPG) and 3-aza-dehydroxyl 
lysyl-phosphatidylglycerol (DP3AdLPG) 
1.6.2. Effect of lysylation on AMP activity 
Most antimicrobial peptides are cationic peptides whose specificity is in part due to electrostatic 
interactions between their charged residues and the anionic phospholipids of the outer leaflet.
95
 
The charge screening that occurs when LPG ion-pairs with these anionic phospholipids 
attenuates AMPs interaction with the lipid membrane. It has also been suggested that the LPG 




Rehal et al. found that at physiological pH, LPG was able to attenuate the activity of magainin. 
Andrä et al. studied the effect of LPG on the behaviour of both helical and -sheet-forming 
peptides and found that the functionalization had very different effects on NK-2, melittin, or 
arenecin, the first two of which fold into helices while the third is a -hairpin.
91
 They found that 
while melittin was not affected by the lysyl headgroup, NK-2 was rendered inactive as even its 
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membrane binding capabilities were hindered.
91
 Both of these peptides are of similar length (26 
and 27 residues, respectively) but they differ in their net charge. While melittin has a net charge 
of +6, NK-2 has a net charge of +10.
96
 This higher concentration of positive charge over a 
similar surface area (as they both form helices) may be the reason why NK-2 cannot sufficiently 
accumulate at the lipid interface to insert transmembrane. Arenicin, a 21-residue peptide with a 
+6 charge, was strongly modulated by the lysyl headgroup.
97
 However, unlike NK-2, arenicin 
could still bind to the interface. 
1.7. Specific Aims 
The aim of this thesis is to develop a better understanding of the interfacial folding behaviour of 
GL13K so that it’s secondary structure, interfacial orientation and organization can be correlated 
with its mechanism of action and activity. This understanding will be achieved by studying 
GL13K at the air/water interface in the absence and presence of a lipid monolayer, the latter to 
represent the outer leaflet of bacterial membranes. 
In the first manuscript (Chapter 3), we studied the surface behaviour of GL13K to establish an 
understanding of the peptide’s interfacial activity in the absence of phospholipids. This 
manuscript is of particular importance given the recent findings of -sheet forming AMPs that 
exhibit amyloid behaviour at physiological pH. Experiments coupling the air/water interface with 
spectroscopic and diffraction techniques were conducted to determine whether GL13K forms 
fibrils at interfaces. The relevant theory of the techniques will be described in Chapter 2. 
In the second manuscript (Chapter 4),  we investigated the interfacial behaviour of GL13K when 
interacting with anionic model membranes. In previous work by the DeWolf group, the 
selectivity of GL13K was examined by introducing cholesterol into anionic and zwitterionic 
bilayers at 40 mol%.
47
  To elucidate whether the effect observed was induced by the higher 
viscosity of lower permeability of the DOPG:Ch 60:40 membrane, four lipid systems were 
studied and compared. These included DOPG, DOPG:Ch mixtures and a DOPG:DPhPG 
mixture. Varying the model membrane composition enabled us to probe the effect of membrane 
viscosity on lipid-peptide interactions.  
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In the final manuscript (Chapter 5), the role of membrane composition modification as a 
mechanism of antimicrobial resistance were investigated.  This contribution is specifically 
focused on the molecular mechanisms of resistance conferred via the lysylation of the 
phosphatidylglycerol headgroup. Two representative model membranes were used, namely a 1:2 
and 1:1 mixture of a synthetic lysylphospholipid analogue, DP3AdLPG, and DPPG. The impact 
on lipid chain organization, peptide binding and insertion were investigated using interfacial 
spectroscopy and x-ray scattering methods.  In addition to the conclusions that can be drawn 
regarding AMPs at interfaces, we demonstrated that ion displacement measurements using total 




Chapter 2. Experimental Techniques 
The behavior of GL13K at interfaces (both air/water and lipid interfaces) was studied using 
Langmuir monolayers and the surface-specific characterization techniques which are outlined 
below. 
2.1. Langmuir monolayers 
Langmuir film balances are an ideal approach for the characterization of surface behavior and the 
organization of lipids and peptides spread at the air/water interface. A Langmuir film balance 
consists of a Teflon trough and one or two Teflon barriers that are used for compression (Figure 
2.1). Lipid films are typically spread from volatile solvents with high spreading coefficients (e.g. 
chloroform) onto a water or buffer subphase. Peptide films can either be spread from volatile 
solvents or aqueous solutions. Upon the evaporation of the spreading solvent, the barriers are 
closed and film compression begins. 
 
Figure 2.1 Schematic representation of lipids at the air/water interface after spreading  
When a film is present, the surface tension of water is lowered, and the resulting change is 
reported as surface pressure. A Wilhelmy plate is used to measure the changes in surface tension, 
and surface pressure is the difference between the surface tension of water and the surface 






𝚷 =  𝜸𝟎 −  𝜸  Equation 1 
Where is the surface pressure and 0 and  are the surface tension in the absence and presence 
of the surface active molecules.  
Compression results in an increase in surface pressure as lipid molecules are forced closer 
together. Surface-pressure-area isotherms are analogous to pressure-volume isotherms and can 
be used to determine changes in lipid organization e.g. phase transitions from gaseous to liquid 




Figure 2.2 Schematic of an ideal surface pressure-area isotherm 
 
Langmuir film balances can be coupled with spectroscopic, diffraction, and reflectivity 





2.1.1. Spreading methods 
Traditionally, lipids are spread from volatile solvents at sufficiently large areas that they are 
consider to be in a two-dimensional gaseous phase. However, in the cases where it is preferable 
to use very small subphase volumes e.g. for experiments when large peptide concentrations are 
used, use of the barriers can be forsaken and lipid can be spread until the desired pressure is 
obtained. In the case of the following manuscripts, the biologically-relevant target pressure is 
~30 mN/m.
99
 Using this approach, the full trough need not be used and an insert of smaller 
volume e.g. 20 mL or less can be used. It must be noted that this approach is heavily dependent 
upon the nature of the lipid films that are being used. Lipids that undergo a phase transition may 
not exhibit the same surface behavior when spread to high surface pressures. Moreover, for this 
method, the surface pressure can be measured but cannot be controlled due to the absence of 
barriers. This means that stability of the film is paramount for the success of the experiment. 
 
2.2. Infrared reflection absorption spectroscopy (IRRAS) and 
polarization modulation-infrared reflection absorption spectroscopy 
(PM-IRRAS) 
Both IRRAS and PM-IRRAS can be used to study conformational changes that occur in 
molecules at the air/water interface. As with any other IR technique, absorption of light by 
different functional groups results in distinctive bands associated with transitions between 
vibrational energy levels. Table 2.1 contains some of the IR absorption bands that can be 
observed for lipid and peptides. The CH2 stretching bands of the lipid acyl chains are sensitive to 
both lipid packing and chain conformation. The shift of the asymmetric CH2 stretching band 
from ~2924 cm
-1
 to 2916 cm
-1
 can be correlated to the conformational change of the lipid chains 
from gauche to all-trans i.e. a phase transition.
100
 The symmetric CH2 stretching band can also be 
used to qualitatively track conformational changes (Table 2.1).  
The secondary structure of interfacial peptides can be determined based on the positions and 
intensities of the amide bands. The amide I (mainly C=O stretching) band and amide II (C-N 
stretching and N-H in-plane bending) band are sensitive to hydrogen bonding, thus the band 











CH2 asymmetric stretch 2916-2924
 
CH2 symmetric stretch 2849-2854 
Phospholipid 
headgroup 
C=O stretch (ester) 1710-1740 
PO2
-
 asymmetric stretch 1220-1250 
PO2
-
 symmetric stretch ~1090 
Peptide 
backbone 
Amide I (mostly C=O stretch) 1610-1690 
Amide II (N-H in-plane bend, C-N stretch) 1520-1560 
Amide A (N-H stretch) 3200-3400 
 













 Table 2.2 Assignment of amide I frequencies to peptide secondary structure
101
 
IRRAS involves the reflection of an IR beam of either parallel (s) or perpendicular (p) 
polarization at a range of incident angles usually between 30 and 70°. The reflected light is 
detected at an angle identical to the angle of incidence. The orientation of interfacial molecules 
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can be determined based on the preferential absorption of the s or p polarized light since the ratio 
of the reflected light at a specific angle is dependent upon the orientation of the bond relative to 
the interface. Typically, IRRA spectra are presented as -log(R/R0), where R is the reflectance of 
the sample and R0 is the reflectance of the reference. IRRAS is conducted using a shuttle trough, 
where both troughs contain the same subphase but only the larger sample trough has the movable 
barriers and pressure sensor for sample measurements (Figure 2.3). 










PM-IRRAS is a technique that was developed by Blaudez et al. where the polarization of the 
incident beam is rapidly modulated between s and p polarization and reflected from the 
interface.
104
 A lock-in amplifier is used to electronically filter and demodulate the reflected 
beam. Whereas with IRRAS the IR absorption of the subphase is measured throughout the 
duration of the experiment whenever the trough is shuttled (see below), with PM-IRRAS, the 
subphase spectrum is measured once at the beginning of the experiment. The differential 








  Equation 2 
where S(d) is the signal from the sample and S(o) is the signal from the subphase. 
Both techniques are surface-specific infrared techniques for which the evanescent wave decays 
exponentially with penetration depth. The two techniques compensate water evaporation (and 
subsequent water vapour interference in the 1400-1800 cm
-1
 region of spectra) differently: 
IRRAS does so by using a shuttle trough such that the reflection of the bare subphase can be 
subtracted from the reflection of the sample. This approach minimizes the contribution of water 
vapour to the spectra. The photoelastic modulation in PM-IRRAS removes water vapor 
vibrational bands from the spectra due to the isotropic nature of their absorption i.e. signals from 
bonds that are randomly oriented are detected with lower efficiency. It is for this reason that 
signal from unstructured peptide cannot be measured by PM-IRRAS. 
Comparison of spectra from both techniques with simulations allows for orientation 
determination. In the case of PM-IRRAS data in the subsequent chapters, the orientation of 




2.3. Surface-specific x-ray techniques 
Surface-specific x-ray techniques require high energy x-rays from synchrotron sources so that 
the information obtained can be at the molecular level. Figure 2.4 summarizes the three surface-





Figure 2.4 Schematic representation of the surface specific x-ray techniques at the 
air/water interface: grazing incidence x-ray diffraction (GIXD), x-ray reflectivity (XR), and 
total reflection x-ray fluorescence (TRXF)
106
 
2.3.1. Grazing incidence x-ray diffraction 
Grazing incidence x-ray diffraction is a technique from which information about the packing and 
lateral ordering of crystalline material at the air water interface can be obtained. In the case of 
lipids, this ordered material is typically the alkyl chains, however, peptides have been shown to 
form crystalline organizations as well.  
For GIXD experiments, the constant incident angle i must be lower than the critical angle c, 
where the critical angle is a function of the intensity of the x-ray beam. The diffracted intensity is 
measured as a function of vertical scattering angle f and the horizontal scattering angle 2

 
These are then converted into the in-plane and out-of-plane scattering vector components Qxy 






𝑸𝒙𝒚 = 𝒌√𝐜𝐨𝐬𝟐 𝜶𝒊 + 𝐜𝐨𝐬𝟐 𝜶𝒇 − 𝟐 𝐜𝐨𝐬 𝜶𝒊 𝐜𝐨𝐬 𝜶𝒇 ∙ 𝐜𝐨𝐬 𝟐𝜽𝒙𝒚  Equation 3 
𝑸𝒙𝒚 ≃ 𝒌√𝟏 + 𝐜𝐨𝐬𝟐 𝜶𝒇 − 𝟐 𝐜𝐨𝐬 𝜶𝒊 𝐜𝐨𝐬 𝜶𝒇 ∙ 𝐜𝐨𝐬 𝟐𝜽𝒙𝒚    Equation 4 
𝑸𝒙𝒚 ≃ 𝟐𝒌 ∙ 𝐬𝐢𝐧 (
𝟏
𝟐
∙ 𝟐𝜽𝒙𝒚) + 𝑶𝒓𝒅𝒆𝒓(𝜶𝒇
𝟐)    Equation 5 
𝑸𝒛 = 𝒌(𝐬𝐢𝐧 𝜶𝒊 + 𝐬𝐢𝐧 𝜶𝒇)      Equation 6 
𝑸𝒛 ≃ 𝒌 𝐬𝐢𝐧 𝜶𝒇       Equation 7 
 
From the number of peaks and their positions, the unit cell can be calculated (Figure 2.5).
107,108
 
For lipid films, the parameters include the lattice dimensions a and b, the intervening angle  as 
well as the tilt angle (relative to the normal) and tilt direction of the alkyl chain (Figure 2.6). 
When untilted, and in free-rotator phase, the alkyl chains frequently arrange in a hexagonal 
lattice  
(a=b, =120°). When the acyl chains tilt, the unit cell elongates in the direction of the tilt (the tilt 







Figure 2.5 GIXD diffraction peak patterns for various tilt directions and unit cells (left to 
right): distorted hexagonal with untilted chains, centered rectangular unit cell with tilt 
towards next-neighbor (NN), centered rectangular unit cell with tilt towards next-nearest-
neighbor (NNN), and an oblique unit cell with and intermediate tilt (between NN and NNN) 
 
Figure 2.6 Schematic representation of unit cell parameters a, b, and as well as tilt 
directions NN and NNN. 
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   Equation 8 
𝑳𝑪 = 𝟎. 𝟗 [
𝟐𝝅
𝑭𝑾𝑯𝑴
]  Equation 9 





2.3.2. X-ray reflectivity 
Whereas GIXD only provides information about condensed regions of the film, x-ray reflectivity 
is used to generate an electron density profile that reflects the laterally-averaged vertical 
structure of the film. This is of great importance for localizing the peptide within the lipid 
monolayer i.e. whether it is interacting with the lipid headgroups or has penetrated into the acyl 
chain region. 
X-ray reflectivity probes the electron density variation of the vertical structures at the air/water 
interface and is measured as a function of the vertical scattering vector component (Qz). 
Unfortunately current instruments are only able to measure reflected intensity not phase, so it is 
not possible to directly determine the vertical structure of the film. Instead the reflectivity data 
are normalized relative to the Fresnel reflectivity and fit using the model-independent method 
and boxes of defined thickness, electron density, and roughness. The reflected intensities are 












Figure 2.7 presents the electron density profile generated for the peptide gramicidin A, where the 
x-ray reflectivity data were fit with two boxes. The boxes become less rigid by increasing the 
roughness of the fit. 
 




2.3.3. Total reflection x-ray fluorescence (TRXF) 
TRXF is a relatively new technique that quantitatively measures the elemental composition of 
the interfacial region.
106
 As with GIXD, x-ray beams interact with the interface at a grazing 
incidence thus limiting the depth of penetration to 8 nm from the surface. X-ray emission is 
measured at an offset angle. When an atom is irradiated with a photon of sufficient energy, an 
inner electron is ejected and the vacancy subsequently filled by an outer shell electron. This shift 
between from a higher energy orbital to a lower energy orbital causes the emission of quantized 
energy that is characteristic of the element. Detection of the distinct x-ray fluorescence enables 
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identification of the surface species present; the intensity is calibrated to the surface 
concentration and is used to quatify the relative amounts of these species. The maximum 
intensity of the incident x-ray beam must be greater than the emission energy of the ions or 
elements of interest i.e. to measure the K band of Br
-
 ions (Figure 2.4), an x-ray beam of 15 keV 
or greater is required.  
In this work, this method is used to indirectly monitor the ionic state of the lipids by measuring 
the x-ray fluorescence emission of the counterions that are attracted to the interface.  
2.4. Brewster angle microscopy (BAM) 
BAM is a technique that allows for visualization of the morphology of film at the air/water 
interface and is based on the difference between the refractive indices of the subphase (water) 
and the spread film.
110
 The Brewster angle, B, of a substance is defined as the incident angle at 
which p-polarized light is completely refracted i.e. no light is reflected. The relationship between 




= 𝟓𝟑. 𝟏𝟓°   Equation 12 
In the absence of a film, no reflected light is detected as the p-polarized light is set to the 
Brewster angle of the air-water interface (Figure 2.8). The refractive index of lipids is 
sufficiently different from that of water that, at the Brewster angle of water, the presence of a 
coherent lipid film will result in reflection which can subsequently be imaged. Different phases 
have sufficiently different optical properties that they can be detected. One of the limitations of 
BAM is that only domains that are within the resolution of the microscope can be visualized. 
This means that features that are less than 1 m cannot be visualized with a 532 nm laser and 




Figure 2.8 Schematic representations of the interaction of p-polarized light at the Brewster 
angle of an air-water interface in the absence (left) and presence (right) of a lipid film. 
 
2.5. Atomic force microscopy (AFM) 
AFM is a high resolution scanning probe microscopy that is used to image thin films that have 
been transferred to solid supports. The thin film can be transferred from the air/water interface 
via multiple methods, however, only the Langmuir-Blodgett (LB) deposition method was used.  
LB deposition consists of inserting a piece of mica into the subphase prior to spreading the lipid 
or peptide solution and then, once the desired surface pressure is reached, slowing withdrawing 
the solid support (Figure 2.9a) while maintaining the film at constant surface pressure.
111
  The 
film adheres to the surface and can subsequently be imaged. With AFM, a cantilever scans 
across the surface of the sample in tapping mode due to the soft nature of the film (Figure 2.9b). 
In tapping mode, the cantilever oscillates while scanning the surface. The force amplitude at 
which the tip scans is kept low to prevent damage to the film. Changes in the position of the 
cantilever result in the deflection of the laser beam that has been aligned with the top of the 
cantilever and subsequently this deflection is transformed into an topological image from which 




Figure 2.9 Schematic representation of the Langmuir-Blodgett deposition technique (a) and 







Chapter 3. The interfacial self-assembly of antimicrobial 
peptide GL13K into non-fibral crystalline -sheets 
3.1. Abstract 
The need for new and potent antibiotics in an era of increasing multi-drug resistance in bacteria 
has driven the search for new antimicrobial agents, including the design of synthetic 
antimicrobial peptides. While a number of -sheet forming antimicrobial peptides have been 
proposed, their similarity to -amyloids raises a number of concerns associated with 
neurodegenerative states. GL13K is an effective, synthetic antimicrobial peptide that selectively 
folds into -sheets at anionic interfaces. Moreover, it is one of relatively few antimicrobial 
peptides that preferentially folds into -sheets without bridging disulfides. The interfacial 
activity of GL13K has not been investigated nor its propensity to form amyloidic fibrils. Using 
structural studies at the air-water interface and in the absence of anionic lipids, we demonstrate 
that while GL13K does form crystalline -sheets, it does not self-assemble into fibrils. This work 
emphasizes the requirement for a single charged amino acid in the hydrophobic face to prevent 
fibril formation in synthetic peptides. 
3.2. Introduction 
Antibiotic resistance in bacteria has driven the search for new antimicrobial agents, including the 
design of synthetic antimicrobial peptides whose functionality can be optimized to improve their 
bactericidal capabilities. While the majority of antimicrobial peptides (AMPs) preferentially fold 
into amphipathic -helices and subsequently induce membrane disruption and cell death, there is 
a smaller subsection of AMPs that fold preferentially into -sheets e.g. arenicin-1, protegrin-1, 
tachyplesin, gramicidin S, defensin, and labaditin. 
14–16,19–21
 For the most part, these AMPs 
depend on disulfides to maintain their secondary structures and bactericidal activities.
22–24
 
GL13K is a synthetic thirteen-residue, cationic antimicrobial peptide that effectively kills both 
Gram-positive and Gram-negative bacteria.
112–114
 It has a net positive charge of +5 at 
physiological pH, and biophysical characterization showed that the peptide preferential folds into 
-sheets in the presence of anionic bilayers but remains unstructured in buffer and in the 
presence of zwitterionic membranes.
50
 NMR studies showed that GL13K has a propensity to fold 
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-sheet forming amyloids have been linked to numerous neurodegenerative diseases including 
Parkinson’s disease, Alzheimer’s disease, spongiform encephalopathies (mad cow disease), and 
type II diabetes.
25
  While there is no distinct sequence similarities between amyloid  (A) 
peptides, prion proteins (PrP) and islet amyloid polypeptide (IAPP), all three form the 
characteristic cross- structure.
29
 It has been proposed that there is a functional link between 
antimicrobial peptides and amyloids in that they both disrupt cell membranes and induce cell 
death.
26
 Despite their different sequences and properties, some AMPs have been shown to cross-
 structures,  for example protegrin-1 was found to undergo amyloidosis and form fibrils with 
much faster kinetics than A 1-42,
35
 implying a potential risk in using -sheet forming AMPs as 
antimicrobial agents.  
To further pursue GL13K as a potential therapeutic, it is essential to understand its interfacial 
behaviour and to determine whether it  is a fibril-forming peptide at physiological pH. Previous 
studies showed that GL13K formed twisted fibrils when stored in buffers of pH greater than 9 for 
extended periods
116
 and similarly, deprotonation of the amino-terminus has been shown to drive 
fibril formation in pentapeptides.
117
 Using an approach employed for the study of peptides, 
including amyloid  peptides, NK2, and arenecin,
30,118–120
 we have investigated GL13K 
organization at the air/water interface to ascertain whether the GL13K folds at the air/water 
interface in the absence of a membrane, and if so, whether it preferentially folds into -sheets 
and whether these sheets are aggregated into fibrils. 
 
3.3. Materials and Methods 
3.3.1. Materials 
Sodium phosphate monobasic monohydrate (NaH2PO4·H2O) and sodium phosphate dibasic 
heptahydrate (Na2HPO4·7H2O) salts purchased from Sigma Aldrich and Fischer Scientific, 
respectively were of purity > 98%. All experiments were conducted using 10 mM sodium 
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phosphate buffer that was adjusted to pH 7.4. GL13K (sequence GKIIKLKASLKLL-NH2) was 
purchased from BioBasic Inc. (ON, Canada) with a purity of > 95%. No further purification was 
conducted. Stock peptide solutions of 1-2 mg/mL were prepared by dissolving the peptide in 
ultrapure water (18.2 MΩ cm
-1
) obtained from a Barnstead Easypure II purification system.  This 
water was used to prepare all buffer and peptide solutions. 
3.3.2. Surface Pressure-Area Isotherms 
Surface pressure-area isotherms were obtained using a NIMA Langmuir film balance with a 
surface area of 80 cm
2
. Peptide was spread on the surface of 10 mM sodium phosphate (pH 7.4) 
buffer and allowed to equilibrate at the interface for thirty minutes prior to compression. The 
film was compressed at a speed of 5 cm
2
/min using mobile barriers. Surface pressure-area 
isotherms were measured at least 5 times to ensure reproducibility of the peptide film. All 
experiments were conducted at room temperature. 
3.3.3. Grazing Incidence X-ray Diffraction and X-ray Reflectivity 
Grazing incidence x-ray diffraction (GIXD) and x-ray reflectivity (XR) experiments were 
conducted at NSF’s ChemMatCARS beamline 15 ID-C at Argonne National Laboratory 
(Lemonte, IL, USA). Experiments were conducted using a 340 cm
2 
NIMA Langmuir film 
balance and the same experimental procedure was followed with the exception of the 
compression speed which was increased to 10 cm
2
/min given the larger surface area of this 
trough. The trough was sealed in a chamber and then flushed with water-saturated helium to 
reduce scattering by oxygen in the air.  
The parameters of the x-ray beams were: wavelength 1.239 Å, incidence angle 0.09061°, 
horizontal and vertical sizes  20 m and 120 m, respectively, producing a beam footprint of 
20m by 7.6 cm. The x-rays were diffracted from the air/water interface, and the diffracted 
intensity was monitored using a 2D Swiss Light source PILATUS 100K detector set to single-
photon counting mode. Two sets of slits, one placed in front of the detector and the other placed 
280.0 mm from the sample, were used to minimize intense low-angle scattering. Data was 
patched using software developed by Wei Bu, a beamline scientist at ChemMatCARS. The in-
plane Bragg peaks in the GIXD data were fit using Lorentzian functions using OriginLab 
Graphing and Analysis software. The position and full width at half maximum (FWHM) of these 
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For x-ray reflectivity measurements,
121,122
 the reflectivity intensities at Qz angles ranging 
between 0.01 and 0.7 Å
-1
 were measured. These intensities were then normalized by the Fresnel 
reflectivity and analyzed using a ChemMatCARS software developed by Wei Bu to generate an 
electron density profile. The slab model was used to fit the normalized reflectivity data and 
generate an electron density profile. This electron density profile is an average over the footprint 
of the beam and represents the vertical distribution of electron density in the film. Starting 
electron densities were estimated based on values in the literature followed by optimization to 
improve the fit. 
3.3.4. Polarization Modulation Infrared Reflection Absorption Spectroscopy 
PM-IRRAS experiments were conducted at Université Laval (Québec City, QC, CA) on an 
instrument that has been described in detail by Bourque et al.
123
 A home-built Langmuir film 
balance of surface area 180 cm
2
 and 5 mm depth coupled with a NIMA pressure sensor. Infrared 
light from a Nicolet iS50 Fourier transform IR spectrophotometer (Thermo Scientific, Madison, 
WI) was reflected off the air/water interface at a grazing angle and measured using a 
photovoltaic MCT detector (Kolmar Technologies, Newburyport, MA). The polarization of the 
beam was modulated with a photoelastic modulator PEM-90 (Hinds Instruments, Hillsboro, OR) 
that was set for optimum efficiency at 1600 cm
-1
. 
Spectra were generated from the co-addition of 1024 scans that were recorded at a scanning 
mirror velocity of 0.47 cm/s and a resolution of 8 cm
-1
. Normalized spectra were obtained by 
plotting the difference of the spectra of the covered and bare subphase divided by the spectra of 
the bare subphase. The OMNIC software was used to process the spectra and correct the 
baselines. PM-IRRAS selection rules state that transition dipoles that are parallel with the surface 
will produce positive bands, whereas transition dipoles that are oriented perpendicular to the 
interface will yield negative bands.
124
 Spectra of -helices and -sheets were compared to 





3.3.5. Atomic Force Microscopy (AFM) 
AFM imaging was performed on peptide films transferred onto mica substrate from the air/water 
interface via the Langmuir-Blodgett (LB) deposition method.
111
 By this method, the freshly-
cleaved mica is submerged in the subphase prior to spreading the peptide. Once the desired 
surface pressure has been reached, the substrate was pulled out of the subphase at a speed of 1 
mm/min while holding the surface pressure constant. Transfers were conducted at surface 
pressures of 5, 10, 15, 20, and 30 mN/m, and images were collected in air at room temperature. 
A Nanoscope IIIa (Digital Instruments, Santa Barbara, CA) was used in tapping mode with 
etched silicon cantilevers with a tip radius of <10 nm, frequency of ~300 kHz, nominal spring 
constant of 20-80 N/m and scan rate of 1 Hz. An oscillation amplitude of 175 mV and medium 
damping (~25%) were employed.  
 
3.4. Results and Discussion 
GL13K is extremely surface active on 10 mM sodium phosphate and forms a very stable 
monolayer (Figure 3.1). The critical area, the area at which the peptides begin to interact and 
form a coherent film, corresponds with the dimensions of a fully extended peptide and indicates 
that the peptides lie flat at the interface prior to compression. Brewster angle microscopy has 
been used to visualize in situ changes in morphology in response to compression of peptide 
monolayers.
125,126
 With GL13K, the emergence of a coherent film at higher surface pressures 
yielded a subtle change in light intensity but no distinct morphological features could be 
distinguished (data not shown).  Thus, if peptide aggregates are present, they must be below the 





Figure 3.1 Schematic representation of the sequence of GL13K (inset, hydrophilic and 
charged residues are blue) and surface pressure-area isotherm of GL13K on a 10 mM 
sodium phosphate buffer, pH 7.4 subphase 
Vertical electron density profiles and lateral organization were derived from x-ray scattering 
methods. The electron density profiles (Figure 3.2a) were generated using a two-slab model by 
fitting the normalized x-ray reflectivity data (Supplemental Materials, Table 3.1). The second 
slab was added to improve the quality of the fit and account for the contribution of adsorbed ions 
and structured water.
109
 It was not possible to fit the data to a simple one-slab model. There does 
not appear to be a significant vertical reorganization at the air/water interface as the GL13K film 
is compressed. The electron density profiles imply that there is a single layer of peptide at the 
interface with a diffuse layer of ions directly underneath. The latter likely results from the high 
charge density of the peptide. The electron density and roughness of the second layer decrease 
with increasing surface pressure indicating that the ion layer becomes less diffuse attributed to a 






Figure 3.2 Fitted electron density profiles (a) and Bragg peak profiles as a function of the 
in-plane scattering vector component Qxy (b) for GL13K at the air/water interface at 5, 20 
and 30 mN/m 
While x-ray reflectivity provides information about vertical organization at the interface, GIXD 
provides information about lateral organization. Peptides that organize into crystalline -sheets 
have been shown to exhibit a peak at Qxy ~1.3 and 0.1-0.2 Å
-1
, corresponding to the inter-strand 
spacing due to hydrogen bonding and the repeat distance (end-to-end) between the peptides 
along the backbone axis, respectively.
118,127–129
   
The GIXD intensity (integrated over Qz) as a function of Qxy for GL13K is shown in Figure 3.2b. 
A Bragg peak is observed at the Qxy position 1.32 Å
-1
, but no peak was observed at lower Qxy.  
This shows that the peptide organizes into crystalline -sheets at surface pressures as low as 5 
mN/m, but this crystallinity is one-directional given the absence of the low Qxy peak. The 
crystallinity at 5 and 20 mN/m, given by the correlation length (Supplemental Materials, Table 
3.2), is similar to that observed for A40 but significantly weaker than that of the short, 12-
residue amyloid-like peptide LSFD for which a coherence length greater than 500 Å was 
observed.
130
 As the film is compressed to small surface areas, the crystallinity of the peptide 
peak weakens from a length corresponding to ~ 6 peptides to the point of being negligible at a 
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surface pressure of 30 mN/m. In all cases, the peaks remain at or near Qz = 0 Å
-1
, showing that 
the -sheets are not significantly bending or twisting at the interface.
127
  
To ensure that the method of formation of the film does not alter the peptide organization, GIXD 
measurements were performed and compared for spread monolayers and adsorbed monolayers, 
the latter from both dilute solution and after injection of a concentrated stock into the subphase.  
All three methodologies yield the same Bragg peak, a lack of  Bragg peaks at low Qxy and 
similar electron density profiles (Supplemental Materials, Tables 3.1 and 3.2). 
While GIXD demonstrates a loss of -sheet crystallinity, it does not indicate the overall 
secondary structure of the peptide at the interface. PM-IRRAS provides information about 
ordered secondary structures as well as their orientation at the air/water interface.
105
 Figure 3.3 
shows the PM-IRRA spectra for GL13K spread at the interface. At all surface pressures, the 
amide I band position is ~1620 cm
-1
. Typically, amide I bands of -sheets are at positions closer 
to 1630 cm
-1
, however, the band position can shift as low as 1619 cm
-1
 with increasing number 
of strands.
101
 This supports the GIXD results indicating that GL13K forms an extended -sheet 
network, not just single -strands. A weak second amide I band at 1696 cm
-1
 and the amide II 
band at 1538 cm
-1
 are also assigned to -sheet formation. The ratio of the intensities of the main 
amide I and amide II bands can be used to determine the orientation of the peptide. By 
comparison to simulated data for interfacial -sheets,
105
 it can be seen that the peptide does not 
lie completely flat at the interface and becomes more tilted with compression. The angle of the 
long axis of the peptide relative to normal of the interface (denoted as  by Blaudez et al.) is 
~90° i.e. parallel with the interface, however the angle of the carbonyls relative to the interface 
() is between 0 and 45°. Compression of the film causes the axes of the peptide to become 
more tilted, i.e.  to become smaller and  to become 45°. At 20 mN/m,  is ~70°, and at 30 and 
40 mN/m,  is ~50°. This increase in tilt would explain the slight increase in thickness of the 





Figure 3.3 PM-IRRAS spectra overlay at GL13K surface pressures 5, 20, 30, and 40 mN/m 
To determine if fibrils were forming at the interface, despite the low crystallinity, AFM was 
conducted on transferred peptide films (Figure 3.4). At surface pressures of 15 mN/m and below, 
small amorphous agglomerations (bright spots) can be observed (Figure 3.4a). These resemble 
the structures observed by Ye et al. after GL13K was incubated for 8 days at pH 9.4.
116
 At higher 
surface pressures, the number of small agglomerations decreases. In contrast, Shin et al. 
observed an increase in amorphous agglomerations with increasing surface pressure for films of 
synthetic polypeptides, which they attributed to surface micelle structures
131
 that appear to form  
due to the block copolymer nature of their peptide. In addition to agglomerations, small domains 
that are about 1 nm above the background can also be observed. These domains appear more 
prominently in the transfers conducted at 20 mN/m and grow with further compression (Figure 
3.4b, 3.4c). Although the domains can grow to sizes nominally greater than the lateral resolution 
of BAM, these were not observed due to the high density of smaller domains in the surrounding 
matrix, such that there is insufficient contrast in the optical properties between the phases. The 
height difference between the domain and the background matrix suggests a co-existence 
between ordered -sheets and random coil peptides. Although the thickness of the -sheet 
regions is comparable to that observed for the amyloid-like peptide LSFD deposited onto solid 






Figure 3.4 AFM images of GL13K deposited on mica at 15 (a), 20 (b), and 30 mN/m (c) 
This surface organization of GL13K is in agreement with both experimental and computational 
findings that the propensity to form -sheets does not necessarily imply fibril formation.
33,34
 
Computational studies with eight-residue peptides of varying sequences found a hydrophobic-
polar-hydrophobic (HPH) sequence motif was important for the formation of -sheets.
34
 
Amyloid fibril formation, which is driven by specific coulombic interactions and hydrophobic 
interactions, is dependent on a nucleation seed,
30–32
. For example, the side-chains often form an 
interdigitated steric zipper motif
29
 for which a Ile > Leu mutation has been shown to prevent 
fibril formation by disruption of the close-contact face of the peptides.
33
  
Multiple variables have been suggested as contributors to amyloidosis. Increasing the net 
positive charge of the peptide has been shown to lower peptide self-association even when the 
hydrophobic face of amphipathic peptides is unaltered as this produces a peptide that has a lower 
net hydrophobicity.
132
 Peptide length may also contribute since biomimetic 
3R3
-peptides ranging 
from 8 to 17 -amino acids exhibited a loss of crystallinity and inter-peptide networking with 
increased length.
129
 It has also been suggested that the presence of a lysine on the non-polar face 
modulates peptide self-association.
132
 All of these factors apply to GL13K and explain why it 
does not form fibrils. On the other hand, while protegrin-1 has a net charge of +7, and has 
arginine residues on its hydrophobic face (PDB 1PG1), it does form fibrils. Notably, protegrin-1 
adopts an internal -hairpin conformation held by two disulfide bridges, thus despite its longer 




GL13K is an antimicrobial peptide that assembles preferentially into antiparallel -sheets. At 
high surface pressures, the peptides continue to exhibit -sheet behaviour but lose crystallinity 
and do not form fibrils. This loss in crystallinity appears to be driven by a compression-induced 
increase in peptide tilt. Fibril formation is also likely prevented by GL13K’s net charge of +5 
and the lysine on its hydrophobic face. Since GL13K has been reported to form fibrils at high 
pH, presumably the pH is required to deprotonate the lysine that lies on the hydrophobic face, 
which should have a lower pKa than the amino-terminus, thus driving the hydrophobic 
interactions required for fibril formation. For therapeutic applications, this residue must remain 
protonated to prevent amyloidic behaviour. 
 
3.6. Supplementary Material 
3.6.1. Adsorbed peptide film formation 
The surface behaviour of GL13K in adsorbed films was investigated and compared to the spread 
film reported. These films were prepared using two methods: injection of peptide from a 
concentrated stock solution and pre-dissolution of peptide into a large volume subphase (from 
the same concentrated peptide stock). The main differences between these two approaches are 
the peptide concentration and the adsorption kinetics. In the former, the final concentration of 
peptide is 10 M and the rate of surface saturation is rapid (under five minutes), while in the 
latter the peptide concentration is 200 nM and the peptide is allowed to adsorb over a twelve 
hour period.  
Given the large amount of peptide required for the injection experiment, experiments were 
conducted using a Teflon trough insert of dimensions 6.6 cm x 6.6 cm x 0.35 cm and volume of 
20 mL (GIXD and XR). The overnight incubation of the peptide subphase and subsequent 
compression measurements were conducted on the same trough following the same protocol as 
the spread peptide films. All experiments were conducted using the same 10 mM sodium 
phosphate buffer adjusted to pH 7.4. The results of these experiments have been included below. 
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3.6.2. GIXD and XR fits 
Table 3.1 Fitting parameters for x-ray reflectivity data of all peptide systems, d is the 
thickness of the slab,  is the electron density, and  is the roughness of the slab. Slabs are 




































5 14.8 0.409 1.9 14.2 0.339 3.8 16 
20 15.6 0.406 2.3 10.8 0.343 2.8 18 




5 15.5 0.369 2.9 11.5 0.349 1.0 28 
20 16.1 0.400 2.5 7.8 0.350 1.8 17 
30 16.5 0.401 2.9 8.8 0.347 1.9 13 
GL13K injected 
10 M 














5 1.32 0.0918 4.78 62 
20 1.32 0.0636 4.77 89 
30 - - - - 
GL13K absorption 
0.2 M 
5 1.32 0.0118 4.76 - 
20 1.32 0.0429 4.77 132 
30 1.32 0.0558 4.78 101 
GL13K injected 
10 M 
16 1.32 0.0490 4.77 115 
Table 3.2 Fitted GIXD Bragg peak positions, fitting information for all peptide peaks 
The GIXD peaks were fit as Lorentzian peaks, and the d-spacing and correlation lengths were 
calculated using the values of Qxy and FWHM, respectively. The correlation length for the 
adsorbed GL13K was not included at 5 mN/m because, while the peak was present, it was too 
weak, so the value calculated was not representative of the actual correlation length. 
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Chapter 4. Membrane fluidity governs the insertion of the 
antimicrobial peptide GL13K 
4.1. Abstract 
Antimicrobial peptides have emerged as potential antibiotics due to their ability to 
specifically target and disrupt bacterial cells. Membrane compositional differences, in particular 
the preponderance of anionic lipids in bacterial membranes, is now a well-established basis of 
their selectivity. However, an additional difference between eukaryotic and bacterial membranes 
is their cholesterol content, where cholesterol is a known modifier of membrane rigidity. In this 
work, we probe the impact of membrane fluidity on the interfacial insertion and assembly of the 
antimicrobial peptide GL13K using monolayer model membranes comprising mixtures of the 
anionic lipid 1,2-dioleoylphosphatidylglycerol (DOPG) mixed with either cholesterol  or 1,2-
diphytanoylphosphatidylglycerol (DPhPG). Both cholesterol and DPhPG decrease the 
permeability of membranes, but, while cholesterol increases membrane viscosity, DPhPG 
membranes are known to remain fluid. Surface spectroscopy and x-ray scattering techniques 
show that while the mixture with DPhPG modulated the interaction of GL13K, the presence of 
cholesterol prevented peptide insertion into the lipid acyl chains. The resulting localization of 
GL13K in the headgroup region of the membrane drives the formation of more crystalline -
sheets than in the fluid DOPG or DOPG:DPhPG membranes. This work highlights the role of 
cholesterol, and more importantly the role of membrane fluidity in preventing eukaryotic 
membrane disruption by antimicrobial peptides and in contributing to the membrane selectivity 
of this class of antimicrobials. 
4.2. Introduction 
Abuse of antibiotic administration has resulted in multidrug resistant bacteria. One of the 
promising fields of study for alternative treatment of bacterial infections is antimicrobial 
peptides. Natural antimicrobial peptides are an integral component of innate immunity and are 
effective against a wide range of pathogens.
7
 Many synthetic peptides have been designed with 
modifications to enhance peptide effectiveness, e.g. the addition lysine or arginine residues.
133
 
GL13K (GKIIKLKASLKLL-NH2) is a thirteen residue antimicrobial peptide whose sequence 
has been derived from the sequence in the human parotid secretory protein (hPSP) which is 
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responsible for the protein’s lipopolysaccharide (LPS)-binding capabilities.
47,112
 While the native 
sequence has been shown to be bacteria-agglutinating, GL13K is effective against Gram-positive 
and Gram-negative bacteria, and preventative of biofilm formation and growth while being 
neither hemolytic nor cytotoxic.
112
 
Model membrane studies have been used to develop a better understanding of peptide selectivity 
for bacterial membranes as compared to eukaryotic membranes.
7
 One of the main differences 
between bacterial and eukaryotic membranes is the charge of the outer membrane. While the 
proportions of negatively-charged phosphatidyl glycerol (PG) and phosphatidylethanolamine 
(PE) headgroups vary between Gram-positive and Gram-negative bacteria, bacterial plasma 
membranes consist predominately of anionic lipids.
7,51,52
 Eukaryotic membranes, on the other 
hand, are predominately zwitterionic. The main components are phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI) and 
phosphatidic acid (PA).
53
 Additionally, the cell wall of Gram-positive bacteria and the outer 
membrane of Gram-negative bacteria are both anionic due to the presence of lipoteichoic acid 
(LTA) and lipopolysaccharide (LPS), respectively.
51
 
Circular dichroism (CD) studies of GL13K with model membranes indicated that it is highly 
selective for anionic dioleoylphosphatidylglycerol (DOPG) membranes compared to zwitterionic 
dioleoylphosphatidylcholine (DOPC) membranes.
50
 While the peptide exhibited random coil 
conformation in the presence of DOPC liposomes, it folded into -sheets with DOPG 
membranes. Nuclear magnetic resonance (NMR) studies showed that GL13K did indeed interact 
with zwitterionic membranes at concentrations too low to be detected in solution by optical 
spectroscopy.
115




N-labelled peptides showed that GL13K 
folds into helices in zwitterionic bicelles while it folds into -sheets with as little as 25 mol% 
DOPG.
115
 They determined that the peptide strongly disturbed the lipid bilayer and hypothesized 
that this is due to peptide association and a high peptide density in the membrane. 
The second difference is cholesterol (Ch) content. The concentration of cholesterol in eukaryotic 
membranes varies between 20 and 40%,
55,56
 and it contributes significantly to the membrane 
rigidity and packing density and is associated with the formation of lipid rafts.
54
  Cholesterol 
fluidizes liquid-ordered membranes by disrupting long-range (global) order and condenses the 





subsequent increase in lipid chain packing density of fluid membranes can increase membrane 
viscosity by approximately 16% in DOPC:Ch 60:40 membranes.
71
 Some studies have shown that 
the presence of cholesterol hinders insertion of peptides into lipid bilayers,
57–59
 but whether this 
is due to charge dilution or increased viscosity has yet to be fully resolved. Previous GL13K 
studies showed significant liposome aggregation when GL13K interacts with DOPG:Ch 60/40 
bilayers but no interaction was observed in the DOPC:Ch control.
49
  
 As monolayers mimic the outer leaflet of the phospholipid bilayer, they have been widely 
used to determine the nature and kinetics of interaction of peptides and proteins with lipid 
interfaces.
103,134,135
 Numerous interfacial spectroscopic and diffraction techniques have been 
developed to characterize these peptide/lipid interactions at the air/water interface. In this work, 
the secondary structure and orientation of the peptides at the monolayer were determined with 
polarization modulation infrared absorption spectroscopy (PM-IRRAS), which couples Fourier 
transform IR reflection spectroscopy with rapid polarization modulation.
136
 Information about 
lipid ordering and the formation of crystalline structures was obtained using grazing incidence x-
ray diffraction (GIXD)
134
 while X-ray specular reflectivity (XR) was used to determine 
monolayer thickness and the electron density distribution at the air-water interface, i.e. if the 




While cholesterol may not be present in bacterial membranes, branched lipids, particularly iso- 
and anteiso-branched lipids, are found in abundance.
72
 Diphytanoylphospholipids are chemically 
stable synthetic archael lipids that forms membranes of similar thickness as those formed by 
dioleoyl analogues.
73,74
 They remain highly fluid with disordered chains despite the increased 
packing density of the acyl chains due to the eight additional methyl groups per 
phospholipid.
77,78
 Membranes composed of diphytanoylphosphatidylcholine contain fewer 
packing defects than membranes containing an oleoyl acyl chain, e.g. POPC,
79
 due to this 
increased chain packing density. Mixtures of DOPG and either cholesterol or DPhPG were used 
to alter the membrane permeability and/or fluidity and to probe the impact of these factors on the 




4.3. Materials and Methods 
4.3.1. Materials 
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) and 1,2-diphytanoyl-sn-glycero-3-
phospho-(1'-rac-glycerol) (DPhPG) were purchased from Avanti Polar Lipids Inc. in powder 
form at 99% purity. Cholesterol and HPLC-grade chloroform were purchased from Sigma 
Aldrich. Sodium phosphate monobasic monohydrate (NaH2PO4·H2O) and sodium phosphate 
dibasic heptahydrate (Na2HPO4·7H2O) salts were purchased from Sigma Aldrich and Fischer 
Scientific, respectively, at purity >98%. GL13K (sequence GKIIKLKASLKLL-NH2) 
was synthesized at the University of Minnesota peptide synthesis facility at > 95% purity and 
generously provided by S.-U. Gorr. Stock lipid solutions were prepared in chloroform at 
concentrations ranging from 1-5 mg/mL, and spreading solutions were prepared at 
concentrations of 0.4-0.6 mg/mL. All lipid mixture compositions are reported in mol%. Stock 
peptide solutions of 1-2 mg/mL were prepared by dissolving the peptide in ultrapure water 
(18.2 MΩ cm
-1
) obtained from a Barnstead Easypure II purification system.  This water was used 
to prepare all buffer and peptide solutions. All experiments were conducted using 10 mM sodium 
phosphate buffer that was adjusted to pH 7.4. 
4.3.2. Surface Pressure-Areas Isotherms 
Surface pressure-area isotherms were measured using a NIMA Langmuir film balance with a 
surface area of 80 cm
2
. Lipids were spread from chloroform solutions at amounts such that they 
remained in the gaseous phase and were compressed at a speed of 5 cm
2
/min using mobile 
barriers after a wait period of 10 minutes. All experiments were conducted on 10 mM sodium 
phosphate at room temperature. 
4.3.3. Experiment Design 
Given the large quantity of peptide required to prepare 10 M peptide solutions, experiments 
were conducted using an insert of dimensions 6.6 cm x 6.6 cm x 0.35 cm and a volume of 20 mL 




Lipids were spread dropwise onto the air/water interface until a biologically-relevant surface 
pressure (~30 mN/m)
99
 was reached. Once the surface pressure of the film stabilized, 
measurements of the lipid alone were conducted followed by peptide injection into the sodium 
phosphate subphase for a final peptide concentration of 10 M. The kinetic insertion profile of 
the peptide was monitored using changes in the surface tension.  
 
4.3.4. Surface-specific X-ray Characterization Techniques 
Grazing incidence x-ray diffraction (GIXD) and x-ray reflectivity (XR) experiments were 
conducted at NSF’s ChemMatCARS beamline 15 ID-C at Argonne National Laboratory 
(Lemonte, IL, USA). Experiments were conducted using a 6.6 cm x 6.6 cm x 0.35 cm trough 
insert which was sealed in a chamber flushed with water-saturated helium. The parameters of the 
x-ray beams were: wavelength 1.239 Å, incidence angle 0.09061°, horizontal and vertical sizes 
16 m and 120 m, respectively. The x-rays were diffracted from the air/water interface, and the 
diffracted intensity was monitored using a 2D Swiss Light source PILATUS 100K detector set to 
single-photon counting mode. Two sets of slits, one placed in front of the detector and the other 
placed 280.0 mm from the sample, were used to minimize intense low-angle scattering. Data was 
patched using software developed by Wei Bu, a beamline scientist at ChemMatCARS. The in-
plane Bragg peaks in the GIXD data were fit using Lorentzian functions using OriginLab 
Graphing and Analysis software. The position and full width at half maximum (FWHM) of these 




For x-ray reflectivity measurements,
121,122
 the reflectivity intensities at Qz angles ranging 
between 0.01 and 0.7 Å
-1
 were measured. These intensities were then normalized by the Fresnel 
reflectivity and analyzed using ChemMatCARS software developed by Wei Bu to generate an 
electron density profile. The slab model was used to fit the normalized reflectivity data and 
generate an electron density profile. This electron density profile is an average over the footprint 
of the beam and represents the vertical distribution of electron density in the film. Starting 
electron densities were estimated based on values in the literature followed by optimization to 
improve the fit. 
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4.3.5. Polarization Modulation Infrared Reflection Absorption Spectroscopy 
PM-IRRAS experiments were conducted at Université Laval (Québec City, QC, CA) on an 
instrument that has been described in detail in Bourque et al.
123
 A trough insert of dimensions 4 
cm x 4.5 cm x 0.3 cm was coupled with a NIMA pressure sensor. Infrared light from a Nicolet 
iS50 Fourier transform IR spectrophotometer (Thermo Scientific, Madison, WI) was reflected 
off the air/water interface at a grazing angle and measured using a photovoltaic MCT detector 
(Kolmar Technologies, Newburyport, MA). The polarization of the beam was modulated with a 
photoelastic modulator PEM-90 (Hinds Instruments, Hillsboro, OR) that was set for optimum 
efficiency at 1600 cm
-1
. 
Spectra were generated from the co-addition of 1024 scans that were recorded at a scanning 
mirror velocity of 0.47 cm/s and resolution of 8 cm
-1
. Normalized spectra were obtained by 
plotting the difference of the spectra of the covered and bare subphase divided by the spectra of 
the bare subphase. All spectra are presented as difference spectra such that the lipid spectra have 
been subtracted and the bands represent contributions from the peptide. The OMNIC software 
was used to process the spectra and correct the baselines. PM-IRRAS selection rules state that 
transition dipoles that are parallel with the surface produce positive bands, whereas transition 
dipoles that are oriented perpendicular to the interface yield negative bands.
124
 Spectra were 
compared to the simulated spectra published by Blaudez et al. 
105
 for -sheet forming peptides. 
They defined two angles for -sheets at interfaces: the angle of the axis of the peptide relative to 
normal of the interface () and the angle of the backbone carbonyls relative to the interface (). 
Variation in these angles leads to intensity changes in both the amide I and amide II bands, thus 
the interfacial orientation of the peptide (defined by these angles) can be correlated to the 
intensity ratio (amide I:amide II).  
4.4. Results and Discussion 
Four model membranes were studied to represent a highly charged anionic membrane surface 
(DOPG), minimum and maximum proportions of cholesterol in eukaryotic cells (80:20 
DOPG:Ch and 60:40 DOPG:Ch, respectively), and a comparable maximal proportion of 
phytanol lipid (60:40 DOPG:DPhPG). Surface pressure-area isotherms in the absence of peptide 
(Figure 4.1) show that all four films remain liquid expanded throughout the isotherm and exhibit 
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film collapse at similar surface pressures. The isotherms of the DOPG:Ch films are at much 
lower molecular areas than those of DOPG and DOPG:DPhPG films due to the smaller size of 
cholesterol indicative of the denser packing in these films. From the isotherms the 
compressibility modulus (Cs
-1












  Equation 13 
The compressibility moduli for each of the  DOPG, DPhPG, and mixed lipid (DOPG:DPhPG and 
DOPG:Ch) monolayers are all below 75 mN/m indicating the formation of a fluid, liquid-
expanded phase
139,140
 (data not shown). 
Brewster angle microscopy (BAM)
125,126
 is an in situ visualization technique that was used to 
confirm that the components are miscible at the biologically relevant surface pressure of 30 
mN/m
99
 (data not shown). No distinct morphological features were observed with any of the 
mixed lipid films, indicating that either the domains were below the 1 m resolution of BAM or 
the cholesterol was miscible and the films were homogenous. Bag et al. studied DOPC:Ch 
systems and determined that at 33 mol%, the proportion of cholesterol was not sufficient to 






Figure 4.1 Surface pressure-area isotherms of DOPG, DOPG:Ch and DOPG:DPhPG 
model membranes on a 10 mM sodium phosphate buffer, pH 7.4 subphase 
Peptide insertion was characterized using XR, GIXD, and PM-IRRAS. The normalized 
reflectivity data for each of the films before and after peptide insertion were fit (Table 4.1, 
Supplementary information Figure 4.5) to generate vertical electron density profiles (Figure 4.2). 
These electron density profiles show that the electron distribution of all of the model membranes 
in the absence of peptide are similar. All the films have a distinct acyl chain region (slab 1), 
headgroup region (slab 2), and an ordered water/ adsorbed counterion region (slab 3). 
Cholesterol causes a slight elongation of the acyl chain region of the monolayer (slab 1) and a 
lengthening of the headgroup region. It also lowers the electron density of the headgroup region 
while increasing the electron density of the chains. This is most noticeable with DOPG:Ch 60:40 
(Figure 4.2a).  
The impact of GL13K on lipid organization varies significantly between the four films. In the 
DOPG and DOPG:DPhPG films, there is a substantial shift in the electron density as the electron 
density of the chain region increases and that of the headgroup decreases (Figure 4.2b and Table 
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4.1). This implies that GL13K is inserting sufficiently to disrupt the organization of both regions 
and subsequently reduce the distinct difference in the electron density between the two slabs. 
Such behaviour was observed with the POPG monolayer in the presence of the linear, -sheet 
forming AMP C/S-Ar-1.
141
 In comparison, the DOPG:Ch films undergo relatively minor shifts 
upon interaction with GL13K. DOPG:Ch 80:20 in the presence of GL13K requires an additional 
slab to achieve an acceptable fit. Notably, for this 80:20 DOPG:Ch system, the redistribution of 
the thicknesses and electron densities of the top two slabs imply that the ends of the acyl tails 
have more conformational freedom and space, whereas the three remaining slabs suggest that 
there is a significant amount of peptide present and the peptides may be structured in multilayers, 
similar to what was proposed by Neville et al. with protegrin.
142
 This peptide multilayer appears 
to be present but less distinct with the DOPG:Ch 60:40 as the thickness of the third slab is 
comparable to the thickness of the third and fourth slabs of DOPG:Ch 80:20 when GL13K is 
present. Thus, the x-ray reflectivity suggests that while GL13K inserts into the tail region in 
DOPG and DOPG:DPhPG 60:40, it is trapped in the headgroup region in DOPG:Ch 80:20 and 
DOPG:Ch 60:40. 
 
Figure 4.2 Fitted electron density profiles of  DOPG, DOPG:Ch 80:20, DOPG:Ch 60:40, 
and DOPG:DPhPG 60:40 before (a) and after (b) peptide insertion 
 































































Table 4.1 Fitting parameters for x-ray reflectivity data of all lipid systems before and after 
peptide insertion, d is the thickness of the slab,  is the electron density, and sigma is the 
roughness of the slab. Slabs are numbered from air to subphase, and the electron density of 




GIXD data show that GL13K forms crystalline -sheets when interacting with any of the four 
model membranes (Figure 4.3). No lipid Bragg peaks are observed, indicating that the peptide 
does not have a measurable condensing effect on the lipid film, even at the highest proportion of 
cholesterol. The position of the Bragg peaks with respect to the in-plane scattering vector Qxy is 
identical for all films (Supplemental Information, Table 4.2). Peaks at this position correspond to 
the inter-strand distance for -sheets and have been observed for a range of -sheet forming 
peptides including amyloid  and arenicin-1.
118,127–129
 The correlation length calculated from the 
FWHM is indicative of the extent of crystallinity, i.e. the larger the correlation length the more 
crystalline the system. GL13K in the presence of the DOPG:Ch mixed lipid systems formed the 
most crystalline -sheets, where the correlation length in upon adsorption to DOPG:Ch 80:20 
films was slightly higher. The correlation lengths were almost double of those found for GL13K 











































DOPG 14.0 0.320 3.77 5.7 0.500 3.54 18.0 0.341 3.84    15 
DOPG +GL13K 10.7 0.391 3.74 4.9 0.439 2.95 14.4 0.348 4.05    15 
DOPG:Ch 80:20 14.4 0.335 2.89 5.8 0.491 3.73 18.4 0.340 4.62    26 
DOPG:Ch 80:20 + 
GL13K 
8.9 0.290 3.22 17.4 0.402 4.06 13.4 0.335 3.99 12.9 0.346 1.21 11 
DOPG:Ch 60:40 15.4 0.337 3.82 6.9 0.461 3.61 14.4 0.342 4.15    26 
DOPG:Ch 60:40 + 
GL13K 
14.6 0.339 4.06 8.1 0.446 4.05 29.3 0.342 4.30    10 
DOPG:DPhPG 
60:40 
14.4 0.316 3.79 4.6 0.528 3.74 15.3 0.348 3.84    20 
DOPG:DPhPG 
60:40 + GL13K 
10.8 0.362 3.72 4.7 0.48 4.00 19.6 0.34 4.00    24 
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interacting with DOPG and DOPG:DPhPG 60:40. The peptide correlation lengths with DOPG 
and DOPG:DPhPG 60:40 indicate -sheets of similar crystallinity despite the larger difference in 
intensity (Figure 4.3). This difference cannot be attributed to the intensity of the beam (which 
was comparable among the four experiments) and can only be explained by the presence of 
fewer crystalline -sheet domains within the footprint of the beam. 
 
Figure 4.3 Bragg peaks (in-plane scattering vector Qxy) of GL13K inserted into the lipid 
monolayers at surface pressures ~30 mN/m 
All PM-IRRAS spectra in Figure 4.4 show a distinct amide I band  at ~1620 cm
-1
 and a band at 
1696 cm
-1
 indicating that GL13K is organized into crystalline anti-parallel -sheets at each of 
these interfaces. However, the intensities of the amide I and amide II (positioned at ~1530 cm
-1
) 
bands vary between the four systems, indicating a different peptide orientation in each of the 
films. Blaudez et al.
105
 simulated the spectra for three different values of : 0° (parallel the 
interface), 45° or 90° (perpendicular to the interface). For each of these, they varied the angle of 
the long axis of the peptide relative to normal of the interface () from 0° to 90°. By comparing 
the intensity ratio of the amide I and amide II bands to that obtained by Blaudez et al., the 
orientation of GL13K was be approximated. The GL13K carbonyls appear to be parallel with the 
interface (= 0°) for all systems. GL13K is most tilted in DOPG (~ 45°), with similar tilts in 
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the three mixed lipid films: ~ 70° in DOPG:DPhPG 60:40 and DOPG:Ch 80:20, and ~ 80° in 
DOPG:Ch 60:40.  
 
Figure 4.4 PM-IRRAS spectra overlay of GL13K absorbed to the lipid monolayers 
While x-ray reflectivity and GIXD data indicate that GL13K inserted similarly into DOPG and 
DOPG:DPhPG 60:40, the PM-IRRAS spectra show, via the lower peptide tilt angle, that 
membrane packing induced by the methylene groups of DPhPG does influence peptide insertion. 
Experimental studies using neutron reflectivity have suggested DPhPC membranes have fewer 




On the other hand, Garten et al. hypothesized, based on molecular dynamics simulations, that 
DPhPG caused larger packing defects than mono- and polyunsaturated lipids, and that these 
packing defects promoted adsorption of the much larger (140-residue) -helical protein, -
synuclein
143
 Herein, no direct evidence of increased adsorption was observed, however a more 
extensive study of the adsorption kinetics is required to confirm whether this also occurs with a 
short -sheet forming peptide. Valincius et al. demonstrated that the bilayer conductance of 
DOPC:DPhPC 50:50 membranes was greater than DPhPC membranes but less than DOPC 
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membranes, and theses differences were greater than those between saturated and unsaturated 
chains.
144
 To date, there are relatively few studies on the effect of phytanoyl chains on the kinked 
chains of oleoyl phospholipids. The organization of GL13K in the presence of DOPG:Ch film is 
slightly more complex. Cholesterol induces short-range, local ordering in fluid membranes and 
an increased packing density. This forces localization of the peptide in the headgroup region, in 
agreement with the tilt angles obtained from the PM-IRRA spectra. Presumably, GL13K is 
inserted with its charged face toward the headgroup and the hydrophobic face oriented towards 
the buffer. Hydrophobic interactions would drive the formation of a peptide bilayer, which could 
contribute to the higher crystallinity of the peptide -sheets and the larger peptide slab thickness 
in the x-ray reflectivity. Such a bilayer or even multilayer structure has been proposed for 





Attenuation of AMPs by cholesterol has been reported for gramicidin, protegrin-1 and LL-
37,
57,59,145
 suggesting that eukaryotic cells are protected by more than the zwitterionic nature of 
their outer membranes. However, it was not clear whether this protection was afforded by an 
increase in membrane viscosity or the lower membrane permeability. Despite the additional 
space-filling by the methyl groups in the chain region for DPhPG, which is assumed to 
contribute to the decreased permeability, GL13K readily inserts into DOPG:DPhPG monolayers, 
as evident form the electron density profile obtained by X-ray reflectivity. However, the 
methylation of the acyl chains does modulate the tilt angle of the peptide at the interface, 
presumably due to a reduction in the available space. Cholesterol causes local short-range 
ordering of the acyl chains, which not only leads to decreased permeability but also increased 
viscosity. This effect not only alters the angle of GL13K insertion but the peptide no longer 
inserts into the chain region and is confined to the headgroup region. This forced localization 
drives the increase in peptide crystallinity (the correlation length doubles). This opens the 
discussion of the role of -sheet crystallinity in AMP activity. 
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4.6. Supplemental Information 
 
Figure 4.5 X-ray reflectivity data and corresponding fits normalized by Fresnel reflectivity 
plotted against scattering vector (Qz) of all the lipid films before (circles) and after 
(squares) peptide insertion for DOPG (a), DOPG:Ch 80:20 (b), DOPG:Ch 60:40 (c), and 
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DOPG +GL13K 1.32 0.038 4.76 149 
DOPG:Ch 80:20 + GL13K 1.32 0.015 4.76 377 
DOPG:Ch 60:40 + GL13K 1.32 0.016 4.76 353 
DOPG:DPhPG 60:40 + GL13K 1.32 0.034 4.76 166 
Table 4.2 GIXD fitting parameters for the GL13K Bragg peaks 
The GIXD peaks were fit as Lorentzian peaks, and the d-spacing and correlation lengths were 







Chapter 5. Lysyl headgroup modifications disrupts the 
organization of antimicrobial peptides bound to the 
membrane interface 
5.1. Abstract 
Antimicrobial peptides (AMPs) are thought to target bacteria membranes due to the high 
proportion of anionic lipids in their membranes. Lysyl-functionalization of the negatively-
charged phosphatidylglycerol headgroup in Staphylococcus aureus is one of the ways in which 
bacteria have become resistant to AMPs. Beyond a simple charge-modulation, the molecular 
mechanisms through which lysylation confers resistance remain largely unknown, in particular 
for AMPs that are non-pore forming. Using a -sheet forming AMP, GL13K and lipid 
monolayer model membranes, we show that the presence of lysyl-functionalized 
phosphatidylglycerol headgroup modulates but does not prevent the adsorption of the peptide at 
the membrane interface. The orientation of the lysyl headgroup, which can loop back on itself or 
extend from the membrane surface, and the corresponding exposure of the cationic charge appear 
to be critical in defining the interaction with the peptide.  We show that in anionic membranes, 
the GL13K adopts a more crystalline -sheet at biologically relevant surface pressures while a 
loss of crystallinity is observed with increasing proportions of lysylphosphoglycerol. These 
results contribute to an understanding of bacterial resistance mechanisms which can be used to 
design more effective AMPs. 
5.2. Introduction 
Antimicrobial peptides are important contributors to the innate immune response of organisms as 
they kill bacteria by permeabilizing their membranes and also attenuate cytokine production and 
macrophage differentiation.
84,146,147
 In the early years of antimicrobial peptide research, it was 
speculated that bacteria would not develop resistance to AMPs as this would require extensive 
modification to their membranes.
84
 Unfortunately, it was later discovered that bacteria have 
developed various mechanisms by which they became less susceptible to AMPs, including 
upregulation of protease production and modulation and subsequent masking of the negative 





 When resistant strains of S. aureus undergo stress, e.g. growth at lower pH or 
in the presence of AMPs, they upregulate the multiple peptide resistance factor gene (MprF) 
which encodes the enzyme aminoacyl-PG synthase which is responsible for the lysyl-
modification of the negatively-charged phosphatidylglycerol headgroups and translocation of the 
lysyl-phosphatidylglycerol (LPG) to the outer leaflet of the plasma membrane.
88,89
 This 
modification shifts the net charge of LPG to either +1 or to net neutral, depending on the 
protonation state of the phosphate (pKa ~3),  the alpha amine (pKa ~6.5), and the epsilon 
(terminal) amine (pKa ~10).
91–93
 Rehal et al. proposed that the epsilon amine loops up to interact 
with the phosphate of the LPG, a neighboring cardiolipin or DPPG in the membrane.
93
  
Most antimicrobial peptides are cationic peptides whose specificity is in part due to the 
electrostatic interactions that occur between their charges residues (typically lysine or arginine) 
and the anionic phospholipids of the outer leaflet.
95
 The charge screening that occurs when LPG 
ion-pairs with these anionic phospholipids then prevents AMPs from interacting with the lipid 
membrane. It has also been suggested that the LPG further inhibits the penetration of AMPs by 
decreasing the membrane permeability to cationic species.
87
 Rehal et al. found that at 
physiological pH, LPG was able to attenuate the activity of magainin. Andrä et al. studied the 
effect of LPG in liposomes and planar bilayers on the behaviour of both helical and -sheet-
forming peptides and found that the functionalization had very different effects on NK-2, 
melittin, arenecin, of which the first two fold into helices and the third is a -hairpin.
91
 To 
elucidate the nature of the lipid/AMP interactions at the outer leaflet surface, our study used lipid 
monolayers coupled with x-ray diffraction techniques and surface IR.  
Due the labile nature of the ester linkage in the lysyl-phosphatidyl headgroup,
93,94
 a stable 
synthetic analogue, 1,2-dipalmitoyl-3-azo-dehydroxy lysyl-phosphatidylglycerol (DP3adLPG), 
was synthesized (Figure 5.1). Whereas prior studies used model membranes comprising  
dipalmitoylphosphatidylglycerol (DPPG), DP3adLPG, and cardiolipin,
93
 the models for this 




Figure 5.1 Chemical structures of dipalmitoylphosphatidylglycerol (DPPG), lysyl-
phosphatidylglycerol (LPG) and 3-aza-dehydroxyl lysyl-phosphatidylglycerol 
(DP3AdLPG) 
Rehal et al. found that the proportion of lysyl-phosphatidylglycerol in the membranes of 
methicillin-resistant strains of S. aureus (MRSA) was greater in cultures grown at pH 5.5 as 
compared to those grown at pH 7.4.
90
 The cultures grown at pH 5.5 contained ~55% LPG, while 
those grown at pH 7.4 contained ~30%. Based on these findings, two representative model 
mixtures were used, namely DP3AdLPG:DPPG 1:2 and 1:1, with the single component DPPG 
monolayers used as a control. These monolayers were studied in the absence of peptide then 
compared to their organization in the presence of peptide. The AMP used was GL13K which is a 
thirteen-residue cationic peptide with net charge of +5 whose sequence was derived from the 
human parotid secretory protein (hPSP).
112
 Additionally, it preferentially forms extended -
sheets at anionic lipid interfaces,
50,115
 so the effect of the lysyl headgroup on peptide self-
assembly can be determined. 
5.3. Materials and Methods 
5.3.1. Materials 
The 1,2-dipalmitoyl-rac-glycero-3-phosphoglycerol (DPPG) was purchased from Avanti Polar 
Lipids and DP3AdLPG was synthesized at the Institute of Pharmaceutical Science, King’s 
College London according to the procedure previously reported.
148
 Purity was confirmed by 
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NMR, MS and TLC. Cesium bromide, cesium hydroxide, and EDTA are purchased from Sigma-
Aldrich at purity > 98%. GL13K (sequence GKIIKLKASLKLL) was purchased from BioBasic 
Inc. (ON, Canada) with a purity of > 95%.  
Lipid solutions were prepared in HPLC-grade chloroform purchased from Sigma-Aldrich such 
that final concentrations were 1 mM. The subphase used in all experiments was 1 mM CsBr, 50 
M EDTA, pH adjusted to 7.4 using 1 mM CsOH. To ensure a homogenous distribution of 
peptide, the subphase was prepared by addition of GL13K from an aqueous stock solution no 
greater than 2 mg/mL such that the final concentration was 300 nM. 
5.3.2. Film preparation 
Three lipid films were investigated: pure DPPG, DP3AdLPG:DPPG 1:2, and DP3AdLPG:DPPG 
1:1. For all experiments, the lipid spreading solution was prepared from stock spreading 
solutions of the pure lipids. These mixed spreading solutions were spread on the subphase. For 
experiments in the absence of the peptide, monolayers were spread in the gaseous phase and 
subsequently compressed. For experiments with the peptide, the lipid was spread on a peptide 
containing subphase until a surface pressure of 2-3 mN/m was reached after which peptide 
absorption was allowed to occur for ninety minutes prior to compression. In all cases the surface 
pressure increased by 4-5 mN/m with peptide adsorption. The surface behaviour of these films 
and subsequent behaviour of GL13K were characterized using grazing incidence x-ray 
diffraction, total reflection x-ray fluorescence and infrared reflection absorption spectroscopy. 
5.3.3. Grazing Incidence X-ray Diffraction (GIXD) 
GIXD experiments were conducted at beamline P08 at PETRA III of DESY (Hamburg, 
Germany), where the photon energy was 15 keV ( = 0.826 Å). The incident beam is set at the 
grazing incidence i = 0.07 degrees. The diffracted signal was measured using a vertically-
oriented position sensitive (PSD) detector (MYTHEN, PSI, Villigen, Switzerland) and scanning 
through 2 which is correlated to the in-plane component Qxy of the scattering vector Q. A 
Soller collimater was used to limit the in-plane divergence of the diffracted beam to 0.09°. The 
out-of-plane component Qz of the scattering vector was derived from the position of the PSD 
channels which spans the range 0.0 to 1.2 Å
-1
. Integration of the Bragg peaks over a defined Qz 
range and subsequent fitting with Lorentzian functions was used to determine the Bragg peak 
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position. Similarly, the position of the Bragg rods in Qz was determined by integrating over a 
defined Qxy range and fitting with a Gaussian function. The tilt of the lipid chains is obtained 
from the Qz positions of the peaks, and the in-plane lattice repeat distance were determined using 
Bragg’s law d = 2π/Qxy.
107
 Data were exported using MATLAB and Bragg peaks and rods were 
fit using OriginLab. 
Experiments were conducted using a temperature-controlled R&K Langmuir trough (Riegler & 
Kirstein, Potsdam, Germany) at 20 °C.  
5.3.4. Total Reflection X-ray Fluorescence (TRXF) 
TRXF measurements were conducted on the same films as the GIXD measurements. The X-ray 
spectra were recorded with an Amptek X-1235DD detector that was set at an offset angle, and 
the peaks of interest were fit as Lorenztian functions using OriginLab. The intensities of the 
spectra were determined to be within 5% of each other by comparing the maximum intensities of 
the Compton (direct beam) peak.  
5.3.5. Infrared Reflection Absorption Spectroscopy (IRRAS) 
IRRA spectra were measured using a Vertex 70 FT - IR spectrometer (Bruker, Germany) 
coupled with an R&K Langmuir film balance (Riegler & Kirstein, Potsdam, Germany). The 
trough and external reflectance unit were sealed in a container to minimize fluctuations in 
atmosphere and water vapour. Experiments were conducted with an incident IR beam at 40°. 
Spectra were collected on both a reference trough and a sample trough via a shuttle trough such 
that 200 scans were co-added for the s-polarized light and 400 scans were co-added for the p-
polarized light. Reflected light was detected at an angle equal to the incident angle by a MCT 
detector with a resolution of 8 cm
-1
. The spectra are plotted as –lg(R/R0), where R is the 
spectrum of the sample and R0 is the spectrum of the reference. Spectra were collected every 2 
mN/m until a surface pressure of 40 mN/m or greater was reached. 
5.4. Results 
In the absence of peptide, all three lipid systems exhibit three Bragg peaks, indicating an oblique 
unit cell with a tilt azimuth between nearest neighbour and next nearest neighbour (Figure 5.2a). 
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The fitted peak positions and corresponding unit cell parameters are shown in the supplemental 
information (Supplemental Tables 5.1-5.5).  
In the absence of peptide, all films show a typical decrease in the tilt angle as the film is 
compressed (Figure 5.2b). At all pressures, the tilt angle of DPPG is lower than the tilt angles of 
the mixtures which are relatively similar to one another. This difference could be attributed to the 
larger headgroup of the DP3AdLPG but also to the attractive interactions between the 
negatively-charged PG headgroup and the positive charge of the lysine which has been reported 




Figure 5.2 GIXD contour plot of the diffraction intensity as a function of the in-plane (Qxy) 
and out-of-plane (Qz) components of the scattering vector for DP3AdLPG:DPPG 1:1 in the 
presence of GL13K at a surface pressure 30 mN/m (a) and calculated tilt angles for each of 
the films in the absence (open symbols) and presence of peptide (solid symbols) as a 
function of surface pressure (b) 
Although there is no change in the unit cell with the addition of peptide, i.e. it remains an oblique 
lattice, the GIXD data clearly show the condensing effect of GL13K on the lipid chains at a 
surface pressure of 20 mN/m as the lipid chains have untilted by 5-6° for all systems. As with the 
lipid films in the absence of peptide, the DP3AdLPG:DPPG mixtures with peptide all exhibit a 
linear decrease in tilt angle with increasing pressure. On the other hand, DPPG exhibits an 
increase in tilt upon compression from 20 to 30 mN/m which may be induced by a partial peptide 
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squeeze-out from the tail region to the lipid headgroup region. This relocalization of the peptide 
out of the chain region generates additional space promoting a higher tilt angle. By 40 mN/m, the 
tilt of the lipid chains for all three systems in the presence of peptide converges at ~27 °, which is 
still more tilted than DPPG (with peptide) at 20 mN/m. None of the films return to the 
organization observed in the absence of peptide, even at 40 mN/m, thus even if GL13K is 
squeezed out of the alkyl chain region, the peptide must still be interacting with the lipid films. 
Since GIXD only provides information about crystalline lipid chains, IRRAS was employed to 
monitor the symmetric CH2 stretching bands which are sensitive to their environment.  The 
position of the band shifts from 2925 cm
-1
 for more fluid chains to 2919 cm
-1
 for condensed 
phase chains.
102
 Thus, the impact of the peptide on the lipid phase transitions can be determined. 
As can be seen in Figure 5.3, the addition of the peptide causes both a shift in the phase 
transition to higher surface pressures and a broadening of the gauche-to-all-trans conformational 
change, which is more pronounced in the case of DPPG. Such a broadening of the phase 
transition of DPPG has been observed previously with the -sheet forming peptide arenicin, 
where the peptide lies in the plane of the bilayer, but not the -helical, transmembrane pore 
forming peptide melittin.
97
  The end of the phase transition at 30 mN/m appears to correlate with 





Figure 5.3 Position of the CH2 asymmetric stretching band from the IRRA spectra of 
DPPG and DP3AdLPG:DPPG 1:2 in the presence and absence of GL13K as the lipid film 
is compressed 
GIXD and IRRAS showed a significant effect of peptide on DPPG films but a reduced impact on 
the DP3AdLPG:DPPG mixed films. TRXF provides an indirect method of evaluating the 





) at the lipid surface.  In the absence of peptide, as should be expected with an anionic lipid 
film, there is significantly more Cs
+
 adsorbed at the lipid-subphase interface than Br
- 
(See 
Supplemental Table 5.6) and the amount of Cs
+
 decreases with decreasing proportion of the 
anionic DPPG.   
For DPPG, the presence of peptide (Figure 5.4) induces a large screening of Cs
+
 ions at all 
surface pressures as the integrated peak intensities are significantly reduced in comparison to the 
same film in the absence of peptide (Table 5.5). At low surface pressures (5 mN/m) where the 
peptide is thought to be embedded in the alkyl chain region, the anionic phosphatidylglycerol 
headgroups would still be sufficiently exposed to attract Cs
+
 and repel Br
-
 from the interface. 
Once peptide squeeze-out into the headgroup region occurs at 30 mN/m, there is a decrease in 
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the amount of Cs
+
 and a concurrent increase in the amount of Br- detected at the interface.  As 
the pressure increases to 40 mN/m there is a sharp increase in the Cs
+
 at the interface (to be 
discussed below).   
The mixtures show neither a large adsorption of Cs
+
 ions in the presence of peptide at higher 
surface pressures. This can be attributed to repulsion either by the presence of the cationic 
peptide or by the cationic lysyl headgroups. At all surface pressures, the amount of adsorbed Br
-
 
exceeds the amount observed in the absence of peptide and increases as the film is compressed. 
This supports the hypothesis that GL13K is present in the headgroup region of the lipid 
monolayers.  A significant difference between the 1:1 and 1:2 mixtures can be observed at 30 
mN/m, where the 1:1 ratio has significantly more adsorbed Br
-.
 However, by 40 mN/m the 
amount of Br
-
 present is again similar between the two mixtures. In order to understand these 
changes, the impact of film composition on the secondary structure and organization of the 
peptide itself must be investigated. 
 
Figure 5.4 Integrated TRXF peak intensities for the cesium ion emission energy bands 
(L1,L2, L1, and L2) and bromide ion emission energy bands (K) for lipid films in the 
presence of GL13K 
Both IRRAS and GIXD can additionally be used to probe the peptide secondary structure since it 
has been previously shown that GL13K forms crystalline -sheets (Chapters 3 and 4). Interfacial 
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crystalline -sheets have been shown to exhibit a GIXD Bragg peak at Qxy ~1.32 Å which 
correlates to the interstrand distances.
118,127–129
 A relatively weak diffraction peak at 
approximately Qxy = 1.32 Å is observed for all three lipid films, but not at all surface pressures. 
For GL13K interacting with the DPPG and DP3AdLPG:DPPG 1:2 films, the peptide only 
becomes crystalline at higher pressures (see Figure 5.5) as no Bragg peak is observed at surface 
pressures below 30 mN/m. Notably, the film is more crystalline with DPPG (see correlation 
lengths given in Table 5.6) and only crystalline at 30 mN/m for DP3AdLPG:DPPG 1:2. 
Corresponding IRRAS spectra (Figure 5.6) for DPPG films show the appearance of an amide I 
band at 1619 cm
-1
 indicative of -sheet formation at pressures greater than 29 mN/m (a similar 
band was not observed for the DP3AdLPG:DPPG 1:2 mixture, but may be masked by the amide 
band of the AdLPG headgroup). In the DP3AdLPG:DPPG 1:1, the film with the lowest negative 
charge,  the GIXD shows that it forms crystalline -sheets at lower surface pressures (20 mN/m) 
but loses crystallinity with further compression. At high surface pressures, incorporation of 
DP3AdLPG into the film induces either peptide unfolding or the disruption of extended -sheets 
into smaller fragments, both of which could explain the large presence of Br
-
 at the interface.  
 
Figure 5.5 GIXD data for DPPG (left), AdLPG:DPPG 1:2 (center), and AdLPG:DPPG 1:1 
(right) showing the Qxy range in which crystalline -sheet diffraction peaks can be found. 
 































































At the low concentrations employed, GL13K has low surface activity in the buffer used over the 
90 minute time-scale over which the peptide is allowed to adsorb when there is no lipid present, 
i.e. no significant increase in surface pressure is observed. Thus, any peptide adsorption to the 
interface that is observed is due to an attraction to the negatively-charged phosphates of the 
phospholipids This attraction induces the increased pressure during the incubation. There appear 
to be two different resultant organizational changes occurring, depending on the film 
composition: with lower proportions of DP3AdLPG, the peptide -sheets become more 
crystalline with compression, while in the system for which DP3AdLPG is the majority 
component, the reverse is true.  
In the presence of DPPG, GL13K does not form crystalline -sheets until ~30 mN/m, at which 
point it has been squeezed out from the acyl chain region. The crystallinity of GL13K increases 
with further compression. This suggests that at low surface pressures (< 10 mN/m), while the 
lipids are still liquid expanded, the amphipathic peptide inserts into the chain region where it has 
hydrophobic interactions with the acyl chains and electrostatic interactions with the 
phosphatidylglycerol headgroup.  This incorporation of peptide into the membrane enables it to 
remain unstructured at the air/water interface (amide I band) and concomitantly prevents chain 
ordering in the lipids (CH2 stretching band). At the physiologically relevant surface pressure of 
30 mN/m, the peptide appears to be squeezed out of the chain region and is trapped among the 
lipid headgroups where it forms crystalline -sheets. This increases the charge screening of the 
headgroups and reduces the amount of bound Cs
+
 to the phosphate, while the presence of the 
exposed cationic peptide concurrently increases the attraction of counterions (Br
-
) to the 
interface. As the surface pressure increases to 40 mN/m, the higher peptide crystallinity and re-
balancing of counterions suggests the formation of more localized  domains of with a high 
density of peptide. 
The behaviour of GL13K in the DP3AdLPG:DPPG 1:2  is similar to that seen with GL13K and 
DPPG, with the IRRAS showing a broadened phase transition due to the incorporation of 
unstructured (GIXD) peptide (GIXD) at low surface pressures and subsequent squeeze-out of the 
peptide into the headgroup region inducing crystalline -sheets. The major difference occurs at 
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40 mN/m where the peptide is no longer crystalline (GIXD). The DP3AdLPG lysine may extend, 
rather than loop, at higher compressions, which either causes the formation of smaller, less 
crystalline -sheets or it drives a proportion of the peptide to unfold into an extended 
conformation. In either case, the lysyl headgroup does not prevent interaction between GL13K 
(evident from both the lipid GIXD and the low number of counterions at the interface) and the 




For the system with the highest proportion of DP3AdLPG, DP3AdLPG:DPPG 1:1, GL13K is 
already structured into crystalline -sheets prior to compression. Whereas the other two films 
have a net negative charge, the situation with DP3AdLPG:DPPG 1:1 is less clear. The alpha 
amine has been reported to have a pKa of 6.5 such that this amine may be partially charged, 
leading to a film that is either neutral or has a slight negative net charge.  Moreover, this charge 
could depend on the headgroup conformation and compression state. The ion-pairing of the 
phosphate with the DP3AdLPG amines clearly reduces the driving force for penetration of the 
peptide into the acyls chain region, forcing it to reside in the headgroup region. This highlights 
that the penetration of the peptide into the acyl region is not just based on peptide amphipathicity 
but requires the electrostatic ion-pairing with the lipid phosphate. Nevertheless, the peptide 
resides at the interface, as is evident from both GIXD and IRRAS, and still forms crystalline -
sheets.  As the film is compressed, the extension of the DP3AdLPG headgroup, rather than 
looping, exposes the charged amine leading to unfolding or smaller -sheets, as described above.  
The greater proportion of DP3AdLPG induces this disruption at lower surface pressures.   
The role of the lysyl headgroup in producing bacterial resistance is not as simple as a charge-
modulation-preventing interaction. Additionally, one has to discriminate between peptides that 
insert transmembrane to form pores and those that induce membrane disruption via a carpet 
and/or detergent mechanism. In the case of the former, the charge of both the membrane and the 
peptide play a significant role. For example, Andra et al. found that while melittin was not 
affected by the lysyl headgroup, NK-2 was rendered inactive as even its membrane binding 
capabilities were hindered.
91
 Both of these peptides are of similar length (26 and 27 residues, 
respectively) but they differ in their net charge. While melittin has a net charge of +6, NK-2 has 
a net charge of +10.
96
 This higher concentration of positive charge over a similar surface area (as 
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they both form helices) may be the reason why NK-2 cannot sufficiently accumulate at the lipid 
interface to insert transmembrane. Similar to melittin, the bacteriocidal activity of Arenicin, a 21 
residue peptide also with a +6 charge, was strongly modulated by the lysyl headgroup.
97
  
However, it was shown to still bind to the interface.  This may be associated with the secondary 
structure and mechanism of association with the membrane. Arenicin forms a two-stranded 
antiparallel -sheet via a -hairpin which binds laterally at the interface.  Its activity (and the 
activity of a linear derivative), however, derives from its ability to oligomerize and form 
transmembrane toroidal pores.
150
 GL13K has been shown to act via a carpet mechanism
50
 and 
does not orient transmembrane (Chapter 4). For such peptides, the insertion of the peptide into 
the plane of the monolayer or bilayer causes acyl chain disruption depending on the depth of 
penetration.  The previous work on the interaction of the -sheet forming arenicin with the lipid 
bilayer focused only on the shift of the main phase transition by monitoring the acyl chain 
conformation using IR. We also see the same shift and broadening of the phase transition, 
however GIXD provides additional evidence that even in the condensed phase, the peptide 
binding to the headgroups can induce subtle organizational changes within the lipids. 
Additionally, we were able to show the influence of the DP3AdLPG on the crystallinity of the 
peptide aggregates bound to the surface. 
5.6. Conclusions 
The lysylation of the headgroup of DP3AdLPG does not prevent peptide adsorption. However, at 
biologically relevant surface pressures, it can attenuate the formation of crystalline -sheets. 
Higher proportions of AdLPG lower the surface pressure required to observe this effect.  The 
orientation of the DP3AdLPG headgroup appears to be a key parameter, and this is controlled by 
both compression and composition. DP3AdLPG hinders crystalline -sheet formation potentially 
by disrupting the hydrogen bond network once compression and membrane packing have driven 
it into the lipid headgroup region. 
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5.7. Supplemental Information 
    




  Qxy Qz Qxy Qz Qxy Qz 
DPPG CsBr 20 xc  1.351 0.769 1.388 0.657 1.473 0.112 
 
w 0.067 0.3 0.098 0.3 0.021 0.3 
  Lc 85   58   276   
30 xc 1.384 0.699 1.411 0.602 1.479 0.097 
 
w 0.080 0.3 0.044 0.3 0.018 0.3 
  Lc 71   128   318   
35 xc 1.400 0.663 1.428 0.549 1.485 0.114 
 
w 0.066 0.3 0.061 0.3 0.020 0.3 
  Lc 86   93   290   
DP3AdLPG:DPPG CsBr 20 xc 1.322 0.847 1.331 0.749 1.467 0.098 
1:2   w 0.05 0.306 0.087 0.306 0.017 0.306 
    Lc 112   65   330   
  30 xc 1.349 0.768 1.367 0.685 1.473 0.083 
    w 0.033 0.302 0.620 0.302 0.0180 0.302 
    Lc 170   9   313   
  40 xc 1.388 0.692 1.4339 0.591 1.479 0.101 
    w 0.064 0.3 0.135 0.3 0.01966 0.3 
    Lc 89   42   288   
DP3AdLPG:DPPG CsBr 20 xc 1.314 0.812 1.33 0.6656 1.466 0.14717 
1:1   w 0.020 0.3 0.041 0.3 0.0161 0.3 
    Lc 227  
137   351   
  30 xc 1.352 0.768 1.363 0.669 1.472 0.099 
    w 0.031 0.3 0.061 0.3 0.0174 0.3 
    Lc 184   92   325   
  40 xc 1.381 0.699 1.403 0.618 1.477 0.081 
    w 0.044 0.3 0.166 0.3 0.0168 0.3 
    Lc 130  
34   337   
 
Table 5.1 GIXD fitted peak position (xc in Å
-1
), peak width (w) and correlation length (Lc in 





    




  Qxy Qz Qxy Qz Qxy Qz 
DPPG 300 nM 
GL13K CsBr 
20 xc  1.375 0.632 1.408 0.511 1.482 0.121 
 
w 0.027 0.505 0.036 0.505 0.0208 0.505 
  Lc 207   158   271   
30 xc 1.340 0.753 1.388 0.609 1.47324 0.144 
 
w 0.128 0.340 0.049 0.340 0.01858 0.340 
  Lc 44   115   304   
40 xc 1.373 0.680 1.412 0.517 1.479 0.163 
 
w 0.033 0.349 0.067 0.349 0.0194 0.349 
  Lc 171   84   290   
DP3AdLPG:DPPG 300 nM 
GL13K CsBr 
20 xc 1.356 0.729 1.388 0.563 1.47252 0.16584 
1:2   w 0.034 0.397 0.029 0.397 0.01467 0.397 
    Lc 166  193   385   
  30 xc 1.355 0.710 1.443 0.524 1.4715 0.1862 
    w 0.062 0.424 0.157 0.424 0.0215 0.42408 
    Lc 91   36   263   
  40 xc 1.378 0.70487 1.45916 0.436 1.47575 0.13444 
    w 0.062 0.349 0.09951 0.349 0.0218 0.349 
    Lc 91   57   259   
DP3AdLPG:DPPG 300 nM 
GL13K CsBr 
20 xc 1.328 0.75984 1.386 0.607 1.46778 0.15313 
1:1   w 0.049 0.47 0.136 0.47 0.02149 0.47 
    Lc 115   42   263   
  30 xc 1.353 0.70341 1.442 0.600 1.472 0.103 
    w 0.070 0.04256 0.043 0.043 0.020 0.043 
    Lc 81  133   287   
  40 xc 1.376 0.632 1.401 0.521 1.476 0.111 
    w 0.045 0.349 0.023 0.349 0.02 0.349 
    Lc 126  246  283   
 
Table 5.2 GIXD fitted peak position (xc, in Å
-1
), peak width (w) and correlation length (Lc 






Table 5.3 Unit cell and tilt parameters calculated from Bragg peak and Bragg rod positions 







System Subphase Pressure a b  tilt Axy 
DPPG CsBr 20 4.99 5.13 115 32.0 23.2 
30 4.96 5.06 116 29.0 22.5 
35 4.92 5.02 117 27.1 22.1 
DP3AdLPG:DPPG 
1:2 
CsBr 20 5.12 5.16 113 36.0 24.3 
30 5.05 5.11 114 32.6 23.5 
40 4.91 5.07 117 28.4 22.2 
DP3AdLPG:DPPG 
1:1 
CsBr 20 5.12 5.18 113 36.3 24.5 
30 5.06 5.10 114 32.4 23.5 




System Subphase Pressure a b  tilt Axy 
DPPG  300 nM 
GL13K 
CsBr 
20 4.95 5.07 116 26.3 22.6 
30 5.00 5.10 115 30.9 23.1 






20 5.00 5.12 115 29.8 23.2 
30 4.87 5.19 117 28.5 22.6 






20 4.98 5.20 115 31.5 23.6 
30 4.87 5.19 117 29.2 22.6 
40 4.98 5.07 116 26.5 22.8 
 
Table 5.4 Unit cell and tilt parameters calculated from Bragg peak and Bragg rod positions 








Fraction DP3adLPG Integrated Area of Cs
+
 Integrated Area of Br
-
 
0 5640 42 
0.33 2594 41 
0.5 710 93 
 
Table 5.5 Integrated TRXF peak intensities for the cesium ion emission energy bands 
(L1,L2, L1, and L2) and bromide ion emission energy bands (K) for lipid films at 30 
mN/m when no peptide is present 
System Subphase Pressure 
(mN/m) 
Qxy (Å) FWHM Lc (Å) 
DPPG 300 nM 
GL13K CsBr 
30 1.324 0.0207 273 










8.2 1.318 0.0260 218 
20 1.318 0.0258 219 
30 1.328 0.0615 92 
 
Table 5.6 Fitted peak position in Qxy, corresponding full width at half maximum (FWHM), 




Figure 5.6 IRRA spectra of the amide region of DPPG (a and b) and DP3AdLPG:DPPG 




Chapter 6. Conclusions and Future Directions 
6.1. Interfacial secondary structure of GL13K 
Until recently, GL13K had only been characterized in solution. Our studies thus far with GL13K 
at the air/water interface have demonstrated that it is a short cationic AMP that preferentially 
forms crystalline anti-parallel -sheets at interfaces.  
In Chapter 3, we showed that compression induces the tilting of the peptide which results in the 
loss of -sheet crystallinity. While the peptide remained in -sheets at the interface, the 
positively-charged lysine residues must prevent the peptide from packing into well-defined 
structures. 
GL13K did not assemble into fibrils at the interface or when transferred to solid support. While 
crystalline -sheet formation has been observed in other-sheet peptides, most of these peptides 
are crystalline in two directions. GL13K is only crystalline in one direction and does not 
organize in the head-to-tail direction, neither at the bare interface nor in the presence of lipids. 
Arenicin, a -hairpin peptide, also forms crystalline sheets in two directions as does its linear 




In addition to lacking the head-to-tail ordering, GL13K also loses crystallinity upon 
compression. Multiple factors including GL13K’s short length, +5 charge, and the lysine on its 
hydrophobic face contributed to this behaviour. The deprotonation of this lysine in particular at 
higher pH may explain why Ye et al. observed extensive fibril formation.
116
 An approach to 
determine the extent of the importance of a cationic residue at this position would be to perform 
similar surface assembly studies with GL13K analogues with different residues at this position. It 
would be particularly interesting to compare the glutamine variant as GL13NH2 (native 
sequence) and GL13D/N both have glutamine in this position and previous work has shown that 
variation of as little as one residue between GL13NH2 and GL13D/N can change the membrane 
specificity of a peptide and its mechanism of action.
49
 Similarly, the impact of membrane 
composition on potential fibril formation should be investigated. 
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6.2. Headgroup localization and peptide crystallinity 
Given that AMPs are thought to target compositional differences in membranes, it was essential 
to characterize peptide organization and influence on model membranes. Specifically, we 
investigated the interaction of GL13K with anionic lipid monolayers. In fluid, anionic 
membranes, GL13K formed crystalline -sheets with correlation lengths greater than those 
observed in the absence of phospholipids. This suggests that the electrostatic interactions 
between the lysine side chains and the phosphatidylglycerol headgroups stabilize the peptide’s 
supramolecular organization. This electrostatic interaction induces the adsorption of low 
concentrations of peptide.  
In Chapter 4, we showed that GL13K preferentially inserts into both the headgroup and tail 
regions of the phospholipid monolayer and that greater space-filling nature of the branched lipids 
did not prevent peptide penetration into the acyl chains but did modulate the angle of insertion. 
Cholesterol increased membrane viscosity by inducing local ordering and, subsequently, 
prevented peptide insertion beyond the headgroup region. The forced localization would prevent 
the “flip and dip” transition
151
 where the peptide reorients itself at the interface to bury its 
hydrophobic face in the acyl chain region. This leaves the hydrophobic residues exposed and 
drove the peptide to form more crystalline -sheets. Our x-ray data suggest that additional 
peptides adsorb from the subphase and provide the hydrophobic interactions to stabilize the 
peptide bound to the membrane interface. Previous bilayers studies suggested that GL13K drove 
aggregation of DOPG:Ch 60:40  liposomes (DLS data and visualized by cryo-TEM).
49
 The 
results of Chapter 4 support this hypothesis (Figure 6.1) and suggest that the exposed 
hydrophobic face of the peptide surface bound in the headgroup region could be responsible for 
inducing this aggregation via the hydrophobic effect. Whether the peptide crystallinity 






Figure 6.1 Schematic representation of mechanism of attack proposed by V. Balhara when 
GL13K interacts with DOPG:Ch 60:40 
6.3. Relationship between -sheet crystallinity and peptide function 
There does not appear to be a direct correlation between peptide crystallinity and peptide activity 
as GL13K is most crystalline when trapped among lipid headgroups. While peptides can still 
disrupt membranes via more discrete mechanisms like charged lipid clustering and membrane 
thinning/thickening (Figure 1.4), GL13K causes the most membrane disruption when it inserts 
into the acyl tail region. Neutron diffraction has been used to follow such changes
90,152–154
 and 
could be used to identify the mechanisms of disruption for GL13K in crystalline -sheet, -
strand and random forms. 
The lack of direct correlation between crystallinity and peptide activity is also shown in Chapter 
5 as peptide crystallinity wa influenced by both lipid composition, lipid density, charge dilution 
and the lysyl functionalization of DP3AdLPG. In the pure anionic (DPPG) film, GL13K does not 
fold into crystalline -sheets until the film was compressed to physiologically-relevant surface 
pressures when it was forced into the headgroup region, much like what was observed with the 
DOPG films. The -sheets must be stabilized by the phospholipid headgroups or else 
crystallinity would be lost much like what was observed in Chapter 1. The presence of 
DP3AdLPG modulated, but did not prevent, the adsorption of the peptide at the membrane 
interface. The orientation of the lysyl headgroup, which can loop back on itself or extend from 
the membrane surface, and the corresponding exposure of the cationic charge appear to be 
critical in defining the interaction with the peptide.  More extensive IRRAS or PM-IRRAS 
experiments studying the headgroup orientation of AdLPG in each of the mixtures are required 
to characterize the looping and unlooping of the lysyl headgroup. Deuteration of the lysyl 
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headgroup would shift IR absorption so that the secondary structure of GL13K can be resolved 
beyond the crystallinity of -sheets. NMR studies with labelled-headgroups or peptides would 
also contribute to this discussion and may explain the driving force behind the loss of 
crystallinity that was observed with increasing proportions of lysyl-phosphatidylglycerol and 
compression of the DP3AdLPG-containing films. X-ray reflectivity would contribute 
information about the localization of GL13K in each of these membranes. The effect of the 
lysylation appears to extend beyond mere electrostatic repulsion given that GL13K adsorbed to 
all three films and the shift in surface pressure during the incubation period was comparable 
between all three films. 
The model membranes studied in this thesis were limited to binary systems in an attempt to 
design a bottom-up approach by which the mechanism and specificity of GL13K could be 
clarified. However, these models are not representative of the complexity in composition of 
bacterial membranes. While the membranes are predominately negatively charged, membrane 
composition varies even between species of bacteria.
51,52
 None of the models discussed in this 
work addressed the contribution of phosphatidylethanolamine headgroups in bacteria,
51
 
especially since the ethanolamine headgroup is smaller than the PG headgroup.
155
  
S.-U. Gorr and collaborators synthesized an all D-enantiomer version of GL13K whose 
bactericidal activity is greater than that of GL13K.
156
 D-peptides are of current interest due to the 
proposed ability to evade proteolysis.
157,158
 Moreover, the chiral environment of the lipid 
membrane may induce changes to the interaction of the peptide at the interface. While Zhou et 
al. found that D-GL13K peptides are more susceptible to fibril formation at higher pH, at this 




A sequence modification that may improve the activity of GL13K (either enantiomer) would be 
to substitute one or more of the lysine residues with arginine residues. While both residues are 
cationic, it has been observed that arginine interacts more strongly with anionic phospholipids 
that lysine.
159
 Simulations have suggested that while the amino group in lysine only interacts 





 Again, single and multiple substitutions would provide information about the 
relative contributions of each of the lysine residues.  
Finally, the influence of GL13 peptide sequence on secondary structure and peptide/lipid 
interactions has not been studied beyond the work of Abdelhosseni and Balhara.
49,112
 The GL13 
peptides GL13NH2, GL13DN, and GL13K vary in three or fewer residues and they all have very 
different activities. GL13K is bactericidal, while GL13NH2 and GL13DN are both bacteria-
agglutinating and hemoagglutinating, however, only GL13DN is hemolytic. Biophysical 
characterization with model membranes has shown that unlike GL13K which interacts 
preferentially as β-sheets with negatively-charged membranes and remains unstructured in buffer 
and in the presence of zwitterionic liposomes, GL13NH2 and GL13D/N shows less specificity 
and appear to favour -helical structures even in buffer.
49
 Investigation of these differences in 
preferred secondary structures will contribute to the discussion of the relationship between 
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